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This work develops new methodology for Bayesian dependent mixture
models and dependent random partitions with applications to biomedical data.
A mixture model implies a random distribution over partitions by randomly
assigning individual observations to latent subpopulations that correspond to
the distinct components of the mixture. Subpopulations are typically homo-
geneous, but heterogeneous accross groups. In the biomedical applications
studied here, the mixture components capture different levels of gene/protein
expression, distinct stages of cellular development or the response to exposi-
tion to distinct drugs. Multiple forms of dependence are considered in order
to more accurately model biological features of the studied applications, in-
cluding dependence over time, dependence by arrangement on a tree and by
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1.1 Objectives and Outline
This work develops new methodology for Bayesian dependent mixture
models and dependent random partitions with applications to biomedical data.
A mixture model implies a random distribution over partitions by randomly
assigning individual observations to latent subpopulations that correspond to
the distinct components of the mixture. Subpopulations are typically homo-
geneous, but heterogeneous accross groups. In the biomedical applications
studied here, the mixture components capture different levels of gene/protein
expression, distinct stages of cellular development or the response to distinct
drugs. Multiple forms of dependence are considered in order to more accu-
rately model biological features of the studied applications, including depen-
dence over time (Chapter 2), dependence by arrangement on a tree (Chapter
3) and by shared match with paired cell lines (Chapter 4).
Summary and contributions
1. In Chapter 2, we model changes in protein expression after cell lines are
exposed to drugs (protein inhibitors) in an reverse phase protein array
(RPPA) experiment. We allow for clusters of proteins with different
1
treatment effects, and allow these clusters to change over time. The
proposed dependent random partitions define a refinement and coagu-
lation of protein clusters over time. We implement the approach using
a time-course RPPA dataset consisting of protein expression measure-
ments under different drugs, dose levels, and cell lines.
Biologic motivations: The biologic motivation for the experiment and
the developed inference approach is in to determine which proteins are
affected by each inhibitor and what is how intense is the effect based on
the dose that is administered.
Contributions: We developed a time-dependent random partition mod-
el that is defined by a sequence of random refinements and coagulations
at random change points. The model includes monotonicity as implied
by the application. In the motivating application, such dependence ac-
counts for the identification of the proteins that are affected by drugs,
although the proposed model can also be used in different applications
that exhibit similar patterns.
2. In Chapter 3, we introduce dependent mixture models when the cluster
locations are naturally connected by a spanning tree. The motivating ap-
plication is inference for cell lineage data on the basis of single cell RNA
sequencing (scRNAseq) data for cell differentiation. The terms of the
mixture model are interpreted as distinct cell types, including a known
root cell population and final differentiated cells. We propose prior mod-
els based on prior shrinkage of a minimum spanning tree (MST) of cluster
2
centers.
Biologic motivations: Related inference can eventually help investi-
gators to better understand the process of cell differentiation including
potential targets for treatment of pathological conditions.
Contributions: We develop a dependent mixture model where the
dependence arrises from the nature of the components as the nodes of
an underlying latent random tree. The dependence is represented by
a regularization factor in the prior distribution of the locations of the
nodes and it penalizes over-complex tree structures.
3. In Chapter 4, we construct a novel Bayesian statistical approach for
matching patient samples with cell lines. We propose a statistical ap-
proach that seamlessly combines the output of the Bayesian mixture
model based on a proposal by Parmigiani et al. (2002) with a novel two-
way Bayesian non-parametric (BNP) mixture model that is constructed
as an extension of a BNP bi-clustering model of Lee et al. (2013).
Biologic motivations: Our approach expands on the traditional pre-
cision medicine procedures of using the patients specific omics profile
in order to propose a personalized treatment that is expected to work
the best for that patient. When matching similar cell line profiles to
the patient’s own omics information, we can gather more data to use
in treatment design while still focusing on the patient profile. This ap-
proach also enables less invasive approaches for drug testing, since the
similar cell lines can be used to infer the expected effect on the patients
3
before they receive the treatment.
Contributions: The research described in Chapter 4 makes two impor-
tant methodological contributions in Bayesian non-parametrics: (i) the
seamless integration of the (modified) probability of expression (POE)
model for noise reduction and the nested bi-clustering approach; (ii) the
introduction of a novel random structure to allow probabilistic modeling
of co-clustering between cell lines and patients based on profile similari-
ties via dependent priors on partition models.
Finally, in Chapter 5 we present conclusions and future work. Appendix
A contains a list of well known probability distributions with the parameter-
ization that is used throughout the thesis. Appendix B contains additional
information that details the implementation of the MCMC algorithm that is
discussed in Chapter 2, as well as details on the use of AIC and BIC to select
the number of clusters. Appendix C describes details for the MCMC algorithm
to sample from the posterior distribution under the two models proposed in
Chapter 3: h-MST and s-MST. Finally, Appendix D contains the full con-
ditionals for the Metopolis within Gibbs algorithms that are used to sample
from the posterior distribution under the models described in Chapter 4 POE
model and uder the NobLoc model with matching of cell lines and patients.
1.2 The Bayesian Inference Framework
We introduce notation by way of a brief review of Bayesian infer-
ence for parameter estimation and prediction. Consider a random object
4
Y with an assumed probability distribution that is indexed by a parame-
ter vector θ. Here, Y could be, for example, a random variable, a ran-
dom vector, a random process or even a random measure. With the ob-
jective of understanding the probabilistic behavior of Y, a random sample
y = y1, . . . , yn is collected from Y and, based on it, we produce estimates of
θ. This procedure works because the observed data carries information about
the parameter θ which is mathematically coded in the likelihood function
l(· ; y) : Θ→ R+, defined as l(θ; y) = p(y | θ) as a function of θ, where Θ
is the parameter space and p(y | θ) is the density function (or the probability
mass function) of y. The likelihood function can therefore be interpreted as a
measurement of plausibility for θ in the light of the observed data y.
Under the Bayesian paradigm, subjective prior information about θ
is also considered. Such information is mathematically represented by the
prior distribution π(θ) which is specified unconditionally on the observed data.
Bayes theorem establishes the use of prior and likelihood to update uncertainty
about θ.
Bayes theorem: Let θ ∈ Θ be the parameter, p(θ) the density or proba-
bility mass function a priori, and y the vector of observations with likelihood
l(θ;y) = p(y | θ). Then, the posterior distribution is given by
p(θ | y) = p(y | θ)p(θ)∫
p(y | θ)p(θ)dθ
∝ p(y | θ)p(θ),
5
where the product p(y | θ)π(θ), as well as any of its multiples by any factor
that does not depend on θ, is known as the kernel of π(θ | y).
All information on the parameter θ after seeing the data is contained in
the posterior distribution with associated density (or probability mass func-
tion) p(· | y) : Θ → R+. The posterior distribution is used to calculate
estimates of the parameters as well as to make predictions for new data y∗
through the predictive distribution
p(y∗ | y) =
∫
Θ





p(y∗ | θ)p(θ | y)dθ, (continuous case)∑
θ∈Θ
p(y∗ | θ)p(θ | y)dθ, (discrete case).
The predictive distribution can be interpreted as an average of the new data
likelihood p(y∗ | θ) weighted by the posterior p(θ | y) on the observed data.
The predictive distribution does not depend on θ in its analytical form.
1.3 Bayesian Mixture Models
A large class of attractive models in Bayesian inference, especially in
biomedical research problems, are hierarchical and related mixture models.
Mixture models are probabilistic models obtained from the integration of a
parameterized probability density (or probability mass function) with respect
to a mixing measure on the parameter. For example, Gaussian mixture models
are obtained as
6
p(y | θ) =
∫
N(y | µ,Σ) dGθ(µ,Σ), (1.1)
where N(x | a,B) denotes the density of a (multivariate) Gaussian distri-
bution with mean a and covariance matrix B evaluated at x. The mixing
measure Gθ is typically parameterized by unknown parameters θ, resulting in
p(y | θ) also being parameterized by θ. The model specification is completed
by specifying a hyperprior on θ.
Many different models p(y | θ) can be written as in (1.1), depending
on the choice of the mixing measure Gθ and the prior on θ. We focus on cases
where the integrand in (1.1) is Gaussian, although any other distribuitions
could also be considered.
Example 1.3.1. (Discrete Gaussian mixture model) In the case of a discrete
mixing measure Gθ(·) =
∑
k wkIµk,Σk(·) with Ix(·) denoting a unit point mass
(Dirac measure) at x, we have θ = (wk,µk,Σk, k = 1, . . . , K) and the mixture
reduces to p(y | θ) =
∑K
k=1wkN(y;µk,Σk). Here we allow for either finite
discrete mixtures (K ∈ N) or infinite discrete mixtures (K =∞).
Example 1.3.2. (Student-t as a Gaussian scale mixture) Consider the uni-
dimensional case y ∈ R, with p(y | µ, σ2) = N(y | µ, σ2). If Gα,β(·) is the










p(y | µ, α, β) =
∫





















Example 1.3.3. (Laplace as a Gaussian scale mixture) Consider the univari-






tion. Then (y | λ, µ) ∼ Laplace(λ, µ, 1):
p(y | λ, µ) =
∫ +∞
0




















∝ exp {−λ|y − µ|} .
An important application of the Laplace distribution as a scale mixture of nor-
mals arises in the Bayesian lasso (Park and Casella, 2008) variable selection
approach where the Laplace prior is responsible for an L1 regularization of the
coefficients and the augmentation provided by the scale mixture representation
guarantees conjugacy for the full conditionals of the Gibbs sampler (section
1.4.2), therefore simplifying the algorithm.
8
We focus on discrete Gaussian mixtures as in Example 1.3.1. Imple-
menting posterior simulation, the parameter space is augmented to include
latent group assignment variables (or cluster membership indicators) δi, i =
1, . . . , n for observations yi. The event {δi = k} indicates that observation i is
sampled from the subpopulation k, i.e., (yi | δi = k,µk,Σk) ∼ N(yi | µk,Σk).
The probability vector w = (w1, . . . , wK) then serves as prior for the cluster
membership indicators: P (δi = k | w) = wk.
The final step to define the Bayesian discrete Gaussian mixture model
is to specify the prior for the atoms (µk,Σk)
K
k=1 and for the probability vector
w, i.i., Gθ in (1.1). There are many possibilities for defining such priors. For
finite discrete Gaussian mixtures (K < ∞) a common choice is a Dirichlet
distribution for the weights: w ∼ Dirichlet(η) and an i.i.d. conditionally con-
jugate prior for the atoms: µk ∼ N(µ0,Σ0), Σk ∼ IW (ν,Ψ). To summarize,
the full Bayesian model in this case is:
(yi | δi = k,µk,Σk) ∼ N(yi | µk,Σk),
P (δi = k | w) = wk,
and priors,
w ∼ Dirichlet(η), µk ∼ N(µ0,Σ0), Σk ∼ IW (ν,Ψ). (1.2)
Under the representation of the mixture model in equation (1.1) as
an expectation with respect to a mixing measure Gθ it is natural to inter-
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pret (1.2) as a prior on Gθ, in this case indexed by a fixed dimension vector
of hyperparameters (η,µ0,Σ0, ν,Ψ). In general, prior probability models on
random probability measures such as Gθ are also known aas non-parametric
Bayes models (BNP) (Ferguson et al., 1992). In this sense, mixture models
are naturally linked with BNP priors.
1.3.1 Bayesian non parametrics and mixture models
In contrast to parametric approaches, non-parametric models include
infinitely many parameters which under the Bayesian framework requires a
prior on a space of infinite dimensions. The main motivation for non-parametric
models is the flexibility that is achieved in comparison with a parametric model
with finite dimensional parameter space. In this section we will present some
applications of Bayesian non-parametric (BNP) priors for mixture models.
We start with the arguably simplest non-parametric model on ran-
dom probability measures: the Dirichlet process (DP) (Ferguson, 1973). If
G ∼ DP (G0, α), we say that G is a random measure following a Dirichlet
process with baseline probability measure G0 on a set S and concentration
parameter α. Ferguson (1973) defines G ∼ DP (G0, α) by defining probability
assignments on partitions of S as
(G(B1), . . . , G(BK)) ∼ Dirichlet((αG0(B1), . . . , αG0(BK)))
for any measurable partition S = B1 ∪ . . . ∪ BK for any K ∈ N. The author
shows that the DP is well defined, meaning that there are no inconsistencies
with the random assignment of probabilities through the DP.
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However, the definition provided by Ferguson (1973) does not directly
allow for an easy way of, for example, simulating such random measure. Sim-
ulation of a DP random measure is important to implement Bayesian infer-
ence in models involving DP’s. Sethuraman (1994) provided a very simple
and efficient way of sampling a DP. The procedure is called stick breaking
representation and it works as follows. First generate a sequence of atoms
(θk)
+∞
k=1. For each k ∈ N sample βk ∼ Beta(1, α) and create a probabil-
ity vector w = (wk)
∞
k=1 as w1 = β1, wk = βk
∏
`<k(1 − β`) for K > 1. This
definesG(·) =
∑∞
k=1wkIθk(·). The stick breaking construction by itself already
gives valuable insights on G ∼ DP (G0, α) when G0 is a continuous probabil-
ity measure: (1) G is a discrete probability measure with infinite number of
atoms; (2) the atoms are sampled i.i.d. from the baseline measure; (3) the
atoms are a dense set in the support of G0; (4) α controls the rate of decay of
the weights wk as k →∞.
1.4 Markov Chain Monte Carlo Posterior Simulation
In many important Bayesian models, it is not possible to evaluate poste-
rior integrals analytically. Alternatively, there are many numerical quadrature
integration methods to approximate p(y), such as the trapezoids rule, Simpson
integration formula, Gauss Hermite quadrature and more (for a brief introduc-
tion, see for example Süli and Mayers 2003). Such methods usually work well
when θ is low dimensional because then the construction of the grid of points
to integrate over can be reasonably distributed over the parameter space Θ.
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However, in moderate dimension (say p = 8 or beyond) the construction of
such a grid reaches a prohibitive computational cost.
In these cases, either optimization or simulation based methods are
used. Regarding optimization algorithms, gradient descent for maximum a
posteriori (MAP), expectation-maximization (EM) (Dempster et al., 1977)
and variational inference (Blei et al., 2017) are among the most popular meth-
ods. An issue with optimization approaches is the way uncertainty is treated:
posterior inference under optimization methods is typically limited to point
estimates. In case of variational inference, we can use the variational posterior
q(θ) as an approximation for the true posterior p(θ | y) and report uncer-
tainty in using q. However q could be a poor approximation for p if the space
of variational distributions is too restricted, e.g. under the mean field assump-
tion (independence of the components of θ). See Yin and Zhou (2018) for an
expansion on the commonly used analytic variational distribution family that
produces accurate variational approximations in a broad range of scenarios.
In this work, we will focus on simulation approaches. Perhaps the most
popular is Markov chain Monte Carlo (MCMC), which simulates a random
Markov chain having the posterior p(θ | y) as its invariant distribution. Then
assuming ergodicity, averages over the simulated states approximate posterior
integrals as the algorithm iterates.
Next we describe two popular MCMC sampling schemes in prepara-




Consider a target probability distribution with density π(x) and sup-
port X ⊂ Rd from which we want to obtain a random sample by MCMC
simulation. We suppose that π(x) is analytically available up to a propor-
tionality constant, i.e., π(x) = π∗(x)C−1 where C is unknown and the kernel
π∗(x) is available in analytic form with
∫
X
π∗(x)dx = C. For example, π(x)
could be a posterior distribution in a Bayesian inference problem, i.e., x = θ
and X = Θ with π(θ) = p(θ | y). We already saw that the kernel of the poste-
rior distribution is analyticaly available when the prior p(θ) and the likelihood
p(y | θ) are analytically available.
The objective is to build an irreducible and aperiodic Markov chain
with transition probability p(x̃ | x) having invariant distribution π(x). Such
conditions guarantee the convergence of the Markov chain to its target in-
variant distribution π(x). It is usually easy to build an irreducible aperiodic
Markov chain. A sufficient condition for invariance is the detailed balance
condition.
Detailed balance condition: If π(x̃)p(x | x̃) = π(x)π(x̃ | x), ∀x, x̃ then
π(x) is the invariant distribution of the Markov chain with transition p(x | x̃).
In this case, we say that p(x̃ | x) satisfies the detailed balance condition with
respect to the invariant distribution π(x).
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To create a transition p(x̃ | x) that satisfies the detailed balance con-
dition with respect to π(x) we start with an initial proposal q(x̃ | x) on
X that is irreducible and aperiodic. The initial proposal will usually violate
detailed balance condition, i.e., for some pairs (x̃,x) ∈ X × X, π(x)q(x |
x̃) 6= π(x̃)q(x̃ | x). Suppose without loss of generality that a pair (x̃,x)
satisfies π(x)q(x | x̃) > π(x̃)q(x̃ | x). Then we include the multiplicative
terms 0 < α(x | x̃) < 1 and α(x̃ | x) to form a new transition probability
p(x̃ | x) ∝ q(x̃ | x)α(x̃ | x) under which the pair (x̃,x) satisfies
π(x̃)q(x | x̃)α(x | x̃)︸ ︷︷ ︸
p(x|x̃)
= π(x)q(x̃ | x)α(x̃ | x)︸ ︷︷ ︸
p(x̃|x)
.(1.3)
Analogously, for pairs (x̃,x) satisfying π(x̃)q(x | x̃) < π(x)q(x̃ | x), we take
0 < α(x̃ | x) < 1 and α(x | x̃) where α(x | x̃) is also chosen to satisfy
equation 1.3. We can combine both cases by taking







The chain with transition p(x̃ | x) ∝ α(x̃ | x)q(x̃ | x) satisfies the detailed
balance condition. Notice that α(x̃ | x) can be evaluated even if we only have
the kernel of the target distribution analytically available.
We iteratively sample from the Markov chain with transition probabil-
ity p(x̃ | x) = α(x̃ | x)q(x̃ | x) + (1−α(x̃ | x))Ix(x̃) by first proposing a new
value x∗ from the proposed transition q(x∗ | x) at the current state x that
14
is to be randomly accepted with probability α(x∗ | x). If x∗ is accepted, we
make x̃ = x∗, otherwise we take x̃ = x.
In the context of Bayesian inference, the target invariant distribution
is the posteriori π(x) = p(θ | y) with X = Θ and the acceptance probability
simplifies to
α(θ̃ | θ) =
{
1,
p(y | θ)p(θ)q(θ̃ | θ)
p(y | θ̃)p(θ̃)q(θ | θ̃)
}
.
Pseudocode for the implementation of a Metropolis Hastings transi-
tion probability in the context of Bayesian inference is presented in Algorithm
1. Assuming that the Markov chain is ergodic, the process Θ̂ := {θ(i) : i =
1, . . . ,M} in Algorithm 1 provides an (approximate) Monte Carlo sample from
p(θ | y). See for example Robert and Casella (2013) for details. Averages over
Θ̂ provide the desired approximation of integrals with respect to the target
p(θ | y).
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Algorithm 1: Metropolis Hastings algorithm for posterior samples
1 Initialize x(1) ∼ π0(θ);
2 Choose the proposal q(θ̃ | θ) (irreducible and aperiodic);
3 for (i ≤M) do
4 Propose θ̃ ∼ q(θ̃ | θ(i));




p(y| ˜θ)p( ˜θ)q(θ| ˜θ)
}
;
6 Sample u(i) ∼ Unif(0, 1);
7 if u(i) ≤ α(θ̃ | θ) then
8 θ(i+1) ← θ̃;
9 else
10 θ(i+1) ← θ(i);
11 end
12 end
Possible choices for the proposal q(θ̃ | θ) are
1. Independent proposal: q(θ̃ | θ) = q(θ̃) ∀ θ, θ̃ ∈ Θ. The independent
proposal does not depend on the current state of the chain. The closer
q(θ̃) is from p(θ̃ | y), the higher the chance of accepting proposed values
which defines a better mixing Markov chain.
2. Random walk proposal: q(θ̃ | θ) = q(θ | θ̃), for example q(θ̃ | θ) =
N(θ̃ | θ,V ) for the tunning covariance matrix V . Typically, we take
V = diag(v21, . . . , v
2
d) to be a diagonal matrix. We propose a new value
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centered on the current one. For component k, if v2k is too big, then
the proposal is too erratic, leading to a low acceptance probability. On
the other hand, for values of v2k too small we get a chain with very high
acceptance, but moving too slowly in each iteration, i.e. a slowly mixing
Markov chain. Therefore, some tunning of v2k is usually necessary.
Under both proposals, a sufficient condition for an irreducible and ape-
riodic chain p is Pq(θ̃ ∈ A | θ) > 0 ∀A ⊂ Θ measurable (meaning that q
allows the chain to move to any measurable set within the support Θ within
a single move). In conclusion, the resulting Marokv chain will be ergodic and
will converge to the posterior distribution.
1.4.2 Gibbs sampler
Consider x = (x1, . . . , xd) ∈ Rd and the target distribution π(x) again
analytically available up to an unknown multiplicative normalization constant.
The Gibbs sampler operates by sequentially sampling from the full conditional
distributions π(xk | x−k), k = 1, . . . , d, as stated in algorithm 2 where the
target is, again, the posterior distribution: π(x) = p(θ | y).
Algorithm 2: Gibbs sampling algorithm for posterior samples
1 Initialize θ(1) ∼ π0(θ);
2 for (i ≤M) do
3 Sample component 1: θ
(i+1)
1 ∼ p(θ1 | y, θ
(i)
2 , . . . , θ
(i)
d );
4 Sample component 2: θ
(i+1)









6 Sample component d: θ
(i+1)
d ∼ p(θd | y, θ
(i+1)





1.4.3 Reversible jumps and variable dimensions
Many BNP models involve parameter vectors of variable dimension. In
order to accomodate for this, it is common to extend the Metropolis-Hastings
algorithm to propose transdimensional moves using a reversible jump MCMC
(Green, 1995). In this section, we provide a brief summary of reversible jump
MCMC (RJMCMC). More details and examples are available in Green (1995)
and Richardson and Green (1997).
In the following discussion, let x denote the parameter vector. The
target distribution is denoted by π(x) for transdimensional x ∈ ∪n∈NRn. The
target distribution restricted to Rn is denoted by πn(xn) and it has density
fn(xn). We start defining up and down moves that will respectively increase
or decrease the dimensionality of the parameter. As always in a Markov chain,
transition probabilities are allowed to depend on the current state; for example,
down moves in a mixture model could be proposed by selecting which pair of
the current components (clusters) to merge. For a state x ∈ Rn, the list of
all (finite) possible up and down moves are Mu(x) = {u1(x), . . . , unx(x)} and
Md(x) = {d1(x), . . . , dnx(x)} respectively. We will denote M(x) = Md(x) ∪
Mu(x). Finally, let qm(x) be the probability of using the transition probability
m ∈M(x) when the current state is x.
Furthermore, suppose all up moves u ∈ Mu(x) from any state x to a
state y are obtained by sampling auxiliary variables v ∼ qaux(v) and then
applying the deterministic invertible transformation y = Tu(x,v). Notice that
given the current state x and the up move u, the proposed value y = Tu(x,v)
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is random due to the randomness of v. On the other hand, we will assume that
proposed values from down moves d ∈ M(y) are obtained deterministically,
given the current state y and the down move d. One last definition: αm(x,y)
is the probability of accepting the proposed value of y given the transition
probability m ∈M(x) and the current state x. Notice that αm(x,y) depends
on the auxiliary variable v.
Let |J | = det(∂T/∂x∂v) denote the Jacobian of transformation T .
Finally, the reversible jump MCMC uses the following acceptance probabilities

























A Bayesian Random Partition Model for
Sequential Refinement and Coagulation
2.1 Scientific publication
This work has appeared in Zanini et al. (2019)1. Carlos Tadeu Pagani
Zanini is the first author of the paper and worked on developing the overall in-
ference approach, the MCMC algorithm for posterior estimation, designing the
simulation study, analysing the data, identifying modifications to the model in




In this section, we propose a model for a sequence of partitions that
includes refinement of the initial partition followed by later coagulation. The
model is motivated by an analysis of protein activation over time after an
intervention.
1Full citation: Zanini CTP, Müller P, Ji Y, Quintana FA (2019). A Bayesian
random partition model for sequential refinement and coagulation. Biometrics.1-12.
https://doi.org/10.1111/biom.13047
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A functional protein pathway involves proteins whose expressions are
dependent. For example, expression of a protein can stimulate the expression
of another protein. Usually a stable pathway leads to an equilibrium state
of the expression of all proteins in the pathway, which can be modeled as a
probability distribution. In cancer cells, biological pathways are almost always
disrupted, which shifts the equilibrium state of the protein expression. Effec-
tive cancer drugs, such as targeted protein inhibitors, can help treat cancer
patients by altering protein expression for key biomarkers. Through pathways,
other proteins are subsequently affected which ultimately leads to phenotypes
that are beneficial for patient survival or quality of life. For a new develop-
mental drug, one of the first steps is to test which proteins are affected when
the drug is introduced to the cells. This is typically done by functional as-
says. We consider such an assay in which protein expression of a biological
pathway is measured at the baseline and at multiple time points after a drug
is introduced to cancer cells.
We analyze protein expression data from such functional assays. To
investigate which proteins have their expression levels changed (directly or
indirectly) after being exposed to the drug, we define a Bayesian model for
protein expressions with a time-dependent clustering structure. The under-
lying assumption of the model is a stylized representation of the earlier de-
scription of disrupted protein pathways. We assume that the proteins are
originally clustered in a canonical way with respect to their protein expres-
sions and, after a certain time period of drug exposure, some or all of the
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proteins have their expressions altered, which may lead to a different cluster-
ing structure. As time passes the drug effect wears off, and the clustering
structure of the proteins may revert to the initial state. In other words, we
model protein expression and the treatment effect by arranging proteins in
different subsets (clusters), possibly corresponding to biologic function, with
cluster-specific mean expression levels. Treatment response is modeled by al-
lowing a change in cluster-specific means over a time interval after treatment,
and by adding new clusters to allow for heterogeneous treatment responses.
The model includes random time points to define this time interval after treat-
ment. Methodologically, through a Bayesian modeling framework we propose
an approach that allows inference for such dependent and temporal clustering.
The dependence is on the partitions that define the clusters, rather than on
the distribution of these partitions.
The proposed process is a reduced and simplified version of the more
general fragmentation and coagulation process of Teh et al. (2011). Another
more general model, without explicit modeling of refinement or coagulation,
is proposed in Elliott et al. (2018) who use a hierarchical Dirichlet process to
infer local genetic ancestry from genotype data. The model implies a parti-
tion of subjects into subsets with common ancestry at each locus. Partitions
are allowed to vary across genetic locus and dependence is formalized by a
hidden Markov process. In general, any dependent discrete random probabil-
ity model such as the Dirichlet or Pitman-Yor (PY) processes (Pitman and
Yor, 1987), indexed by discrete time, could be used to induce the desired
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time-dependent random partition. Such models are developed in Caron et al.
(2017) and Rodŕıguez and Ter Horst (2008). Caron et al. (2017) construct a
sequence of random partitions with each partition marginally distributed as
in a PY mixture model, with an additional parameter to control similarity
between partitions. The approach is based on a property of the Ewens sam-
pling formula known as consistency under deletion (Kingman, 1978). However,
these models for sequences of random partitions are more general than what
is needed here and the implied marginal distribution of the random partition
at each time point is the same. In contrast, the assumed monotonicity of
fragmentation and following coagulation is important in our application. It
represents how the treatment affects the proteins (refinement), and that effect
eventually vanishes (coagulation). This desired monotonicity (of adding and
then removing clusters) and the limited data in the motivating application lead
us to construct a much simplified version of such more general models. The
main inference target is the subset of proteins that form the refined partition
clusters, corresponding to the desired subset of proteins that are most affected
by the initial treatment.
2.2.2 Dataset
The motivating data are from an experiment using reverse phase protein
arrays (RPPA) which record the expression of selected proteins in a biological
pathway simultaneously on multiple samples. Multiple cell line samples are
prepared and exposed to multiple protein inhibitors at different dose levels
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(Charboneau et al., 2002). The experimental design is a balanced factorial
structure, including C = 2 cell lines, D = 3 drugs, J = 3 technical replicates,
and L = 4 doses (0, 0.625, 2.5 and 10uM), with expression measurements
of I = 55 proteins recorded at T = 8 different times (0, 5, 15, 30, 60, 90, 120
and 180 minutes) after the drug exposure. The cell cultures are treated with
three protein inhibitors that are often investigated in cancer studies. The in-
cluded drugs act on: Phosphoinositide 3-Kinase (PI3K), which is responsible
for coordinating cell functions such as proliferation, cell survival, degranu-
lation, vesicular trafficking and cell migration (Azadi et al., 2016); Protein
Kinase B (AKT), which promotes growth factor-mediated cell survival, cell
proliferation and inhibits apoptosis through the inactivation of pro-apoptotic
proteins (Nitulescu et al., 2016); and mitogen-activated protein kinase kinase
(MEK), which is an important component of the ERK1/2 signaling pathway
that is often deregulated in cancer cells (Caunt et al., 2015).
Some of the data can be seen in the four panels in the left column of
Figure 2.7. The plots show the data for cell line c = 1 under drug d = 1,
which is the PI3K inhibitor. The horizontal axis is time (in minutes) after
treatment. The vertical axis is protein expression (averaged over J = 3 repeat
experiments). Notice how some proteins have their expressions altered after
the dose is administered. Figure 2.8 shows the same for cell line c = 2.
For an initial exploratory data analysis one could use a fit of the tra-
jectory for each protein and try to identify systematic changes. Figure 2.1,
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Figure 2.1: Smoothing splines based on the J=3 repetitions over time (min-
utes) for each protein in cell line 1 for drug PI3Ki. Cluster structure (repre-
sented in colors) is constrained to be the same for all different doses. Compare
with the data shown in the left column of Figure 5.
case smoothing splines. While the fit is reasonable, it remains difficult to spot
proteins that respond to treatment. By arranging proteins in clusters we will
reduce some of the noise and be able to highlight possible treatment effects.
2.3 Probability Model
Let ycd`ijt denote the expression level for protein i in cell line c, drug
d, dose `, replicate j and time point t. To simplify notation, we drop c and
d from the subindex in the following discussion as they appear in (almost) all
variables. Only one parameter, Σc is common across drugs which we highlight
by including the c subindex for Σc. In addition, some of the hyperparameters
are common across all c, d as indicated below. We use notation for column
vectors such as (an)
N
n=1 = (a1, . . . , aN)
>.
We assume a model y`ijt = µ`it+ ε`ijt, where µ`it is the mean expression
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level for a specific cell line, drug, dose, protein and time, and ε`ijt represent
time-dependent Gaussian errors. Let ε`ij = (ε`ijt)
T
t=1 denote the error vector.
We assume ε`ij
iid∼ N(0,Σc) with Σc denoting covariance matrix, independently
across cell line, drugs, doses, proteins and replicates. Similarly let y`ij =
(y`ijt)
T
t=1 and µ`i = (µ`it)
T
t=1. The joint likelihood becomes
y`ij
ind∼ N(µ`i,Σc), (2.1)
with independence across all subindex values, but dependence of the elements
y`ijt across time t = 1, . . . , T . We assume an inverse Wishart conjugate prior
on the covariance matrices Σc
ind∼ IW(νΣ,V Σ), c = 1, . . . , C, with expectation
V Σ
νΣ−T−1
. Here V Σ is a (fixed) T × T matrix-variate hyperparameter and νΣ ≥
T + 2 are the degrees of freedom. Introducing a more detailed model for
temporal dynamics is not meaningfully possible with the small sample sizes
and only T = 8 longitudinal observations.
We introduce a time-dependent partition of the proteins, which together
with cluster-specific means implies a generative model for the mean protein
expressions µ`i within cell line, drug and dose, and across different time points
t = 1, . . . , T . We first develop the structure for the time-dependent partitions.
Let δt = (δti)
I
i=1 denote the partition at time t of proteins i = 1, . . . , I into κ
t
clusters m = 1, . . . , κt. The random partitions δt are characterized by cluster
membership indicators δti ∈ {1, . . . , κt} with δti = m when protein i is in the
m-th cluster at time t. A key model feature is the prior probability model for
the sequence of partitions δ1, . . . , δT that defines the evolution of the partitions
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over time (as before, separately for each cell-line c and drug d). See below for
the choice of κt – we will reduce it to only two distinct values, κ1 and κ2,
over time. Also, for clarification we note that the dependence should be on
the partitions themselves rather than on their distributions. Modeling the
dependence on the actual proteins, i.e., the cluster membership of proteins,
allows us to represent how the treatment affects each protein.
One desired feature motivated by the nature of the RPPA data analysis
is that partitions should initially start fragmenting (i.e., more subsets should
be formed) up to a certain change point, after which a coagulation process
starts (i.e., merging of clusters into fewer subsets). This reflects the drug
action on proteins. In other words, the drug is expected to alter the regular
expression pattern of the proteins, resulting in more heterogeneous expression
profiles and therefore more clusters. As the drug effect wears off, the expression
of the proteins should revert to the original states, implying a coagulation of
the clusters.
We implement the desired structure with two change-points in time.
The first change point marks the beginning of the refined partition with more
clusters, and the second change point marks the time when the partition reverts
to the original clusters. We let τ 1` (refinement change point) denote the first
change point when the proteins form the finer partition, and let τ 2` (coagulation
change point) denote the second change point. We assume 1 ≤ τ 1` < τ 2` ≤ T
for all cell lines c, drugs d, and doses `. One key feature is that τ 1` and τ
2
` are
specific to dose `. This represents how different doses act faster or slower on
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the proteins. Higher doses are expected to start acting on the proteins earlier
than lower doses, i.e., we expect monotonicity of τ 1` and τ
2
` over doses. We
further assume (τ 1` , τ
2
` )
iid∼ Unif ({(u1, u2) : 1 ≤ u1 < u2 ≤ T − 1}) . Adding an
informative prior would be straightforward. However, even with the (vague)
uniform prior we find little posterior uncertainty on the change points.
The prior probability models for the baseline and fragmented parti-
tions are constructed as Dirichlet-multinomial models for cluster membership
indicators. Let δu = (δui )
I
i=1 for u ∈ {1, 2} denote the two partitions of pro-
teins with u = 1 indicating the original (coarse) partition that applies for
t < τ 1` and t > τ
2
` , and u = 2 indicating the (refined) partition that applies for
τ 1` ≤ t ≤ τ 2` . That is,
δt =
{
δ1, for 1 ≤ t ≤ τ 1` , or t ≥ τ 2` + 1
δ2, for τ 1` + 1 ≤ t ≤ τ 2` .
We assume that P (δ1i = m) = π
1
m for clusters m = 1, . . . , κ1. The prior
for the fragmented partition δ2 is constructed in two steps. First, set δ2i = δ
1
i
with probability γ; second, all proteins i with δ2i 6= δ1i are gathered in the set
A := {i : δ1i 6= δ2i }, and form new clusters by P (δ2i = m) = π2m−κ1 , m =
κ1 + 1, . . . , κ2, i ∈ A. Note that p(δ2 | δ1) does not define δ2 as a partition
nested within δ1. This is why we use the term refinement throughout.
We assume independent priors for γ, π1 = (π
1
1, . . . , π
1
κ1
) and π2 =
(π21, . . . , π
2
κ2−κ1) as γ ∼ Beta(aγ, bγ) π1 ∼ Dir(η1), and π2 ∼ Dir(η2). The
hyperparameters γ,π1,π2 are shared across all cell lines c and drugs d.
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Next, we construct a prior for the mean protein expression µ`i in (2.1)
by defining cluster-specific common values. That is, the partition is linked





i ), if 1 ≤ t ≤ τ 1`
µ∗`2(δ
2
i ), if τ
1
` + 1 ≤ t ≤ τ 2`
µ∗`3(δ
1
i ), if τ
2
` + 1 ≤ t.
(2.2)
In words, µ`it = µ
∗
`u(m) for all proteins in cluster m under dose level ` in
the time interval u = 1, 2 or 3, with the time intervals corresponding to the
initial, fragmented and final partitions respectively (initial and final partitions
are assumed equal). The choice of the piecewise constant mean function in
(2.2) is only for parsimony. Alternatively, one could use a piecewise linear
mean response, without much change in the remaining discussion. The use




`1 allows for a persisting effect of the drug
intervention, short of a complete restriction to baseline.
The model is completed with a prior on the cluster-specific parameters,
(µ∗`u(m) | µ0u, v0u)
iid∼ N(µ0u, v−10u ), µ0u
iid∼ N(µ00, v−100 ) and v0u
iid∼ Gamma(av, bv).
The hyperparameters (µ0u, v0u) are common across cell lines c and drugs d.
In summary, the proposed model constructs a mixture of Gaussian
sampling model for the observed protein expressions over time, with the mix-
ture being induced by the latent partitions δ1 and δ2. In fact, marginal-
izing δ1 and δ2, we find the following mixture of normals sampling model.
Let u1 = (1, . . . , 1, 0, . . . , 0)
>, u2 = (0, . . . , 0, 1, . . . , 1, 0, . . . , 0)
> and u3 =
(0, . . . , 0, 1, . . . , 1)> denote design vectors with 1’s in positions 1, . . . , τ 1` (for
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u1), in positions τ
1
` + 1, . . . , τ
2
` (for u2) and in positions τ
2
` + 1, . . . , T (for u3),
respectively, and let µ∗`(k1, k2) = µ
∗
`1 (k1)u1 + µ
∗
`2 (k2)u2 + µ
∗
`3 (k1)u3 denote
the T -dimensional mean vector for proteins in clusters k1 and k2 under the
initial and the refined partition, respectively. Let N(x; m,S) denote a multi-
variate normal p.d.f. evaluated at x with mean m and covariance matrix S.
Then


















Note how the proposed model is different from models that allow de-
pendence of the distributions for the random partitions. Dependence in the
prior on the random partitions over time would not necessarily enforce the
desired monotonicity of refinement (to represent the treatment effect) and
following coagulation for an actual realization of protein-specific cluster mem-
bership. Here, the dependence is built on the partitions themselves, unlike, for
example, the earlier mentioned model of Caron et al. (2017) where each δt is
marginally distributed according to a PY-style (Generalized Pólya urn) distri-
bution, exploring several ways to relate and control similarity across partitions.
The fragmentation and coagulation feature cannot be represented by models
with invariant marginal distribution. Modeling the desired monotone pattern
of change in the partition is the key motivation for the proposed construction.
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Finally, we would like to comment on the choice of the proposed model
versus a seemingly simpler parametric model, such as a linear mixed effects
model or a regression with splines, as in Figure 1 in the supporting infor-
mation section. While such parametric models could adequately model time-
dependent mean response, inference for protein-specific response to treatment
effects would require corresponding protein- and time-specific random effects.
2.4 Posterior Inference
We implement Markov chain Monte Carlo (MCMC) posterior simula-
tion. Let θ denote the complete parameter vector. For posterior simulation it
is now important to keep track of parameters that are in common across cell
lines c and drugs d. We therefore start to include the subindexes c and d again





























































where κ1 is the number of clusters in time intervals {t : 1 ≤ t ≤ τ 1cd`}
(corresponding to u = 1) and {t : t > τ 2cd`} (or u = 3); and κ2 is the number
of clusters in time interval {t : τ 1cd` + 1 ≤ t ≤ τ 2cd`} (or u = 2). If desired, the
model could easily be generalized to different number of clusters across cell













Although posterior inference is not analytically tractable for this model, condi-
tional conjugacy implies that all full conditionals are well known distributions
that are straightforward to sample from (see Web Appendix A). We therefore
implement MCMC simulation using a Gibbs sampler Markov chain. We run
one common Markov chain for inference across all (c, d), but report inference
on partitions separately for each (c, d). Therefore, in the following discussion
of inference summaries, we drop the cd subindex again.
Point estimates of the cluster-membership indicators are obtained using
the approach proposed by Dahl (2006). After judging (practical) convergence
of the MCMC algorithm, we evaluate for each pair i < j of proteins, the






ij , where K is the Monte Carlo
sample size and p
(k)
ij is an indicator for i and j being allocated to the same
cluster. The p
(k)
ij and p̂ij are combined into (I × I) matrices P (k) = [p
(k)
ij ] and
P̂ = [p̂ij]. We then report as posterior estimated δ̄ the partition corresponding
to the P (k
∗) that minimizes ||P̂ − P (k)||, i.e., k? = arg mink ||P̂ − P (k)||. In
words, k? indexes the Monte Carlo sample whose co-clustering matrix is closest
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to P̂ . Once the point estimate of the clustering structures is obtained, we
run a new MCMC chain with fixed cluster membership indicators to carry
out inference for the remaining parameters, now conditional on the estimated
partition.
Finally, we consider learning about the unknown size κ1 and κ2 of the
partitions. Using transdimensional transition probabilities, such as reversible
jump (Green, 1995), the selection of these parameters could be included in
the same MCMC simulation. However, we found that the implementation
of such transition probabilities is impractical for the proposed model. Con-
sidering a variation of reversible jump for multivariate mixtures of normals
with split and merge proposals that are constructed to maintain marginal first
and second moments (Zhang et al., 2004; Dellaportas and Papageorgiou, 2006)
we find it impossible to achieve acceptable mixing rates of the Markov chain
simulation. The challenge lies in finding a split move that simultaneously pro-
poses reasonable draws for µ∗cd`u(m) across all ` ∈ {1, . . . , L}, u ∈ {1, 2, 3} and
m ∈ {1, . . . , κ1} with high probability. We therefore recommend to use an al-
ternative model selection framework to determine (κ1, κ2). We consider several
criteria, including AIC (Akaike, 1973), BIC (Schwarz, 1978), DIC (Spiegelhal-
ter et al., 2002), and WAIC (Watanabe, 2010) as well as log pseudo marginal
likelihood (LPML). See, for example, Gelman et al. (2014) for a review on
these methods. The specifics of counting the number of parameters, as it is
required to evaluate AIC and BIC are described in Web Appendix B. In the




We carried out several simulation studies to verify that the proposed
model allows for meaningful inference in the context of weak signals and rela-
tively small sample sizes as in the RPPA data. We considered two scenarios,
with several variations.
Scenario 1: We simulated five hypothetical datasets with the following
(true) partition sizes: (κ1, κ2) ∈ {(2, 3), (3, 4), (3, 5), (4, 7), (5, 7)}. In all five
cases we simulated from the model described in section 2.3. The bottom
level hyperparameters were fixed as γ = 0.9, v0u = 5 for u = 1, 2, 3 and
Σc = 0.1I8×8, where I8×8 denotes the 8 dimensional identity matrix. For
any cell line c and dose `, the change points were fixed as (τ 1cd`, τ
2
cd`) = (2, 5)
for d = 1, (τ 1cd`, τ
2




cd`) = (4, 7) for d = 3.
For (κ1, κ2) = (2, 3), (3, 4), (3, 5), we fixed µ0u = (0.5, 1.5, 0.4), whereas for
(κ1, κ2) = (4, 7), (5, 7), we fixed µ0u = (1.0, 1.5, 1.4). The remaining parameters
were randomly generated from the respective prior probability model.
For each dataset we then implement inference in two steps as in section
2.4. First we run 500 MCMC iterations, discarding the first 100 as initial
burn-in under each one of 21 possible pairs of (κ1, κ2). We use the pairs
{(a, b) : a ∈ {2, . . . , 8}, b ∈ {a+ 1, a+ 2, a+ 3} }. This first step evaluates the
different model choice criteria (see below) to select the best pair (κ1, κ2), and
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Table 2.1: Simulation truth and estimate for (κ1, κ2) under alternative model
selection criteria. ? Under simulation truth (5, 7), AIC selects (5, 6).
truth (2,3) (3,4) (3,5) (4,7) (5,7)
BIC (2,5) (2,5) (3,4) (3,6) (5,6)
AIC, DIC,WAIC, LPML (4,7) (3,6) (5,6) (4,7) (8,10)?
then estimates (δ1cd, δ
2
cd) using the approach of Dahl (2006).
In a second step we simulate 5000 more MCMC iterations to imple-
ment inference conditional on the chosen model, i.e., with fixed δ1cd, δ
2
cd,
c = 1, 2, d = 1, 2, 3. The first 2000 iterations are discarded as initial burn-
in. Hyperparameters are fixed as νΣ = 10, V Σ = I8×8, aγ = 1, bγ = 1,
η1 = (1, ..., 1)
> ∈ Rκ1 , η2 = (1, ..., 1)> ∈ Rκ2−κ1 , µ00 = 0, v−100 = 0.4444, av = 1
and bv = 1 to reflect weak prior information.
We implement learning about the cluster sizes (κ1, κ2) as model selec-
tion using various criteria proposed in the literature. We briefly summarize
the results in Table 2.1. BIC always selects a more parsimonious model, and
AIC, DIC, WAIC and LPML always point to the same model (except under
(5, 7)). We conclude to use BIC, as it gives the best trade-off of a good fit and
selecting parsimonious models.
Next we summarize results for the simulation scenario with true (κ1, κ2)
= (3, 5). In this case BIC selects (κ1, κ2) = (3, 4). The objective is to explore
whether inference can recover mean parameters and cluster structure for data
with sample sizes and complexity comparable to the motivating RPPA study.
Figure 2.2 shows estimated partitions under coagulation and refinement, ar-
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proteins proteins proteins proteins
(a) Coagulation: t ≤ τ 1cd`, t > τ 2cd` (b) Refinement: τ 1cd` < t ≤ τ 2cd`
Figure 2.2: Scenario 1: Simulation truth δucd (above horizontal lines) and pos-
terior estimated δ
u
cd (bellow horizontal lines). Each vertical bar corresponds to
a gene, with colors (grayscale) representing their respective estimated cluster
memberships.
ranged by cell line and drug (c, d). In a few cases, we get estimates that merge
two (true) clusters together (e.g., in the estimated partitions δ1cd and δ
2
cd for
(c, d) = (1, 3) and for (c, d) = (2, 1)). In most cases, however, the underlying
cluster structure is accurately recovered and we are able to correctly identify
which proteins are affected by the respective drug (proteins corresponding to
darkest shades of gray in plot (b)).
Figure 2.3 shows estimated cluster membership and mean responses
(first two columns) in comparison with the simulation truth (last two columns)
for one specific combination of cell line and drug (c = 2, d = 3). Comparing
the simulation truth in column 4 with the estimated means in column 2 we
find a good fit for the data. With one less cluster in the refinement stage
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picked by BIC, the model merges the two new clusters (darkest shades of gray
in columns 3 and 4) into only one (darkest shade of gray in columns 1 and 2),
still providing a good fit with a more parsimonious model.
Scenario 1a. We explore prior sensitivity with respect to the prior on
the random partitions and the structure of partitions over time. We first
repeat inference, still with the same data as in scenario 1; but with a different
hyperprior on the random partition, namely π1 ∼ Dir(0.1, . . . , 0.1) and π2 ∼
Dir(0.1, . . . , 0.1). Comparing Figure 2.4(a) with the second column of Figure
2.3 we find no difference with respect to the estimated mean responses.
Scenario 1b. Alternatively we consider inference under a single random
partition that remains invariable over time, that is, using δ2cd = δ
1
cd for all c
and d, but still allowing changing mean levels over time as in (2.2). Figure
2.4 summarizes the resulting inference by showing the simulated data and
the estimated clusters, using the same format as first and fourth columns in
Figure 2.3. Comparing Figure 2.4(b) with the second column of Figure 2.3
shows a substantially deteriorated fit under the reduced model without the
refined partition.
Scenario 2: We consider another hypothetical scenario with a simulation
truth that closely mimicks the estimated effects in the actual RPPA data
analysis. The data ycdi`jt are simulated with parameters fixed at the posterior
estimates obtained in section 2.6, with (κ1, κ2) = (4, 6). Figure 2.5 summarizes
simulation results for c = 2 and d = 1. Using the BIC criterion we select
(κ1, κ2) = (4, 6), matching the simulation truth (with (κ1, κ2) = (4, 7) and
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0 5 15 30 60 90 120 180
Figure 2.3: Scenario 1: Mean-response estimation for one of the simulated
cases (cell line 2, drug 3). Each row corresponds to a different (increasing)
dosage level. Time is measured in minutes on the horizontal axis. Column 1




j=1 y`ijt for the 55 proteins. Each
line corresponds to a specific protein and the color (grayscale) indicates the
posterior estimated cluster (column 1) and the true cluster (column 3). Col-
umn 2 and 4: posterior estimates (column 2) and simulation truth (column 4)
for µi`t with dashed lines denoting estimated refinement and coagulation times





























































































































































































































































































(b) Single partition model: δ2cd = δ
1
cd.
Figure 2.4: Scenarios 1a and 1b: Inference under two variations of the prior
model. Colors (grayscale) denote estimated clusters. Panel (a) shows in-
ference under an alternative hyperprior with a symmetric Dirichlet prior,
π1 ∼ Dir(0.1, . . . , 0.1) and π2 ∼ Dir(0.1, . . . , 0.1). Panel (b) shows inference




(5, 6) being second and third best). Overall, the cluster-specific means are
accurately estimated and the model fits the simulated data, indicating that
inference under the proposed model can report meaningful summaries for the
motivating RPPA data.
2.6 Proteomics Data
Based on BIC we select (κ1, κ2) = (4, 6) (Figure 2.6). While more
complex models (with more clusters) exhibit even better BIC, we find that
the results for those models remain very similar to the ones obtained under
(4, 6), but with several empty and redundant clusters. We therefore proceed
with the more parsimonious model.
We implement MCMC simulation for 5,000 iterations discarding the
first 2,000 as initial burn-in. Hyperparameters are fixed as in the simulation
study under Scenario 1, i.e., νΣ = 10, V Σ = I8×8, aγ = 1, bγ = 1, η1 =
(1, ..., 1)> ∈ Rκ1 , η2 = (1, ..., 1)> ∈ Rκ2−κ1 , µ00 = 0, v−100 = 0.4444, av = 1 and
bv = 1.
Figures 2.7 and 2.8 show estimates of the effect of PI3K inhibitor on
the 55 proteins in cell lines 1 and 2 over time, respectively. Cell line 1 is
the cell line MDA-MB-231 and cell line 2 is MDA-MB-468. Both are derived
from a 51-year-old caucasian woman with metastatic breast cancer. The two
cell lines have been shown to respond differently to chemotherapies and hor-
mone therapies. Here, the goal is to characterize response to PI3K inhibition.









0 15 60 1205 30 90 180
   
   
   











   
   
   




















0 15 60 1205 30 90 180
   
   
   











   
   
   




















0 15 60 1205 30 90 180
   
   
   











   
   
   




















0 15 60 1205 30 90 180
   
   
   











   
   
   













1 cluster 1   cluster 2   cluster 3   cluster 4   cluster 5   cluster 6   
(a) Simulated data (over 4 doses). Data for each protein is shown as a
connected line over time. Colors (grayscale) indicate cluster membership
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1 cluster 1   cluster 2   cluster 3   cluster 4   cluster 5   cluster 6   
(b) Estimated mean expression and cluster memberships. Colors (grayscale)
indicate estimated cluster structure.
Figure 2.5: Scenario 2. Data (panel a) and estimated mean response and




































κ2  =  κ1 + 1
κ2  =  κ1 + 2
κ2  =  κ1 + 3
Figure 2.6: BIC for different number of clusters κ1 and κ2 (the bigger, the
better).
mind the context of this analysis in the early phase of a drug development
and the moderate sample sizes, inference should be understood as hypothesis
generating, and findings should not be over-interpreted.
The first two columns in both figures are as in Figure 2.3 and show the
model fit to the data. Going from top to bottom (increasing dose) in Figure 2.7
one can see that protein S6 pS235/236 decreases with increased PI3Ki dose. At
the same time HER2 is activated by the PI3K inhibitor. These two genes form
singletons in our analysis. The inhibition of S6 and activation of HER2 after
PI3K inhibition have been well reported in the literature (Podsypanina et al.,
2001; Serra et al., 2011). Our analysis for cell line 1, MDA-MB-231 confirms
these findings. In addition, we see that MAPK pT202Y204 is activated in this
cell line as a result of PI3K inhibition. We see increased MAPK expression
5 minutes after the PI3K inhibitor is applied to the samples. The activation
of MAPK as a result of PI3K inhibition is a major known discovery in breast
42
cancer (Liu et al., 2009).
In contrast, results are different in cell line 2, MAD-MB-468 (Figure
2.8). MAPK is briefly inhibited by the PI3K inhibitor instead of being acti-
vated as in cell line 1. This suggests that cell line 2 includes a mechanism that
might reverse the interactions of PI3K and MAPK. Due to large and complex
down-stream pathways regulated by PI3K, the effects of its inhibition can be
tissue-dependent and heterogeneous (Engelman, 2009). This is shown in the
different response of protein expression in the two cell lines of this RPPA ex-
periment. The differential response of MAPK to PI3K inhibition across the
two cell lines could be important in interpreting the reason why they respond
differently to therapies. Discoveries like this are expected to help biologists to
set up new hypothesis for further testing.
Summarizing the refinement at time τ 1 as a distance between δ1 and
δ2 one could use, for example, the Hamming distance between co-clustering











respectively. We find relative (to the number of pairs) Hamming distances
between the partitions δ1cd and δ
2
cd to range from 0.01 to 0.03 depending on the
cell line c and drug d.
Table 2.2 shows point estimates for the refinement and coagulation
times τ 1` and τ
2
` , respectively. For cell line 1 the three drugs (columns) behave
similarly, causing the proteins to refine and revert to te baseline with a similar
delay, without apparent dose effects. Cell line 2 is different from cell line 1 in
that the cells in this line react heterogeneously to the three drugs and doses.
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Table 2.2: Estimated (mode) refinement and coagulation times (minutes): τu`
for cell line c, drug d, dose ` and u ∈ {1, 2}.
cell line 1 cell line 2
drug PI3Ki AKTi MEKi PI3Ki AKTi MEKi
dose/time refin. coag. refin. coag. refin. coag. refin. coag. refin. coag. refin. coag.
0 uM 0 15 0 5 0 15 60 120 60 90 5 120
0.625 uM 0 15 0 5 0 5 60 90 5 90 60 120
2.5 uM 0 30 0 5 0 5 30 120 5 120 15 90
10 uM 0 30 5 30 0 5 0 30 90 120 30 60
In particular, cell line 1 seems to be more robust to the drugs as the refinement
period is very short across doses. That is, the proteins in this cell line in general
do not react to the drugs. For cell line 2, proteins seem to be more sensitive
to the drugs. For the first three dose levels, 0, 0.625, and 2.5 µM , refinement
starts earlier and ends later with increasing dose levels. This is expected as
higher doses will lead to quick reaction and longer duration of the biological
system. Dose level 10 µM is an outlier with a very short refinement period
again. This might be due to the high potency of the high drug concentration
(10 µM is the highest dose level).
Additionally, in Figure 2.9 we illustrate the benefit of the time-dependent
clustering, with only two change points when the partition changes. In the
figure we explore the use of independent clustering at each time point, using
k-means for an easy implementation. While one could still identify a small
number of proteins that seem to have their expression gradually increased or
decreased at higher doses of the PI3K inhibitor, there is substantially more
noise in the summary than in the corresponding plot in Figures 2.7 and 2.8.
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Time (min) Time (min)
Figure 2.7: Results for proteins in cell line c = 1 exposed to PI3K inhibitor
(d = 1). Colors (grayscale) denote distinct clusters with dashed lines corre-
sponding to additional clusters formed at refinement. Columns 1 and 2 show
ȳit and µi`t as in Figure 2.3. The horizontal axis contains the observed times
measured in minutes. Columns 3 and 4 show the original partition before
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Figure 2.8: Same as Figure 2.7, now for cell line c = 2.
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1 2 3 4 5 6 7 8
Dose: 0uM
1 2 3 4 5 6 7 8
Dose: 0.625uM
1 2 3 4 5 6 7 8
Dose: 2.5uM








Figure 2.9: Independent k-means (k=5) estimation of partitions across time
for different doses of PI3K inhibitor administered to cell line 1. For a fixed
column (time index), each color represents the estimated cluster specific mean
for that particular protein (higher expressions are darker).
2.7 Discussion
We introduced a model for finding a subpopulation of proteins that are
most affected by a particular intervention. The key element of the model is a
sequence of random partitions subject to the desired monotonicity. The same
inference – without any change in the probability model – can be interpreted
as inference on mean protein expression over time, with the clusters serving
the purpose of adaptively borrowing strength across proteins, doses, drugs
and cell lines. The latter happens only at the level of hyperparameters. The
approach is meaningful in any inference problem with a sequence of partitions
that include a notion of monotonicity. It is most appropriate when limited
data or high noise leaves more complexly structured models impractical to fit.
Several extensions and generalizations of the proposed model are possi-
ble. With more data one could replace the piecewise constant mean response
by a piecewise linear mean response with little change in the remaining model.
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In the application to the RPPA data it was reasonable to assume that once the
treatment effect wears off the mean response would revert to the initial levels.
Other applications might call for lasting treatment effects, allowing for a dif-
ferent final level. Also, in other applications the use of more than two change
points might be meaningful, with possibly different sequences of refinements
and coagulations.
In the discussion following equation (2.1) we commented on alternative
priors on Σc. In an application with richer data one could alternatively consider
a Gaussian Process prior with more general covariance structure.
The main limitation is the computationally awkward problem of esti-
mating the size of the partitions. With respect to the application, a limitation
is that the described inference targets only mean expression levels, missing
changes that are in the dependence structure. The latter is plausible when the
intervention affects pathways and feedback mechanisms.
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Chapter 3
Dependent Mixtures: Modelling Cell Lineages
3.1 Introduction
This chapter introduces a Bayesian mixture model with dependent prior
on the component-specific parameters. The simplest Bayesian mixture models
assume independent priors on cluster-specific parameters that index the sam-
pling model for each term of the mixture model, motivated mostly by ease of
implementation. For a review of Bayesian inference in mixture models see, for
example, Frühwirth-Schnatter (2006) and Frühwirth-Schnatter et al. (2019,
Chapter 1).
However, in many situations, the observed data structure is not well
supported by independent mixture components. Xu et al. (2016) argue for
priors that favor diverse and parsimonious components in the mixture via de-
terminantal point process. The idea is to favor mixture models with terms
that define meaningfully different subpopulations. This becomes important
if the inference aim is related to a biological interpretation of the underlying
structure. While one can argue that asymptotically posterior inference in mix-
tures will concentrate on a parsimonious structure (Rousseau and Mengersen,
2011), this is not true for any finite sample size unless appropriate model as-
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sumptions are explicitly introduced. In this paper we consider an inference
problem that gives rise to a special type of parsimony in a mixture model.
3.1.1 Modeling cell lineage data
The work developed in this chapter is motivated by the study of cell
lineages. Cell lineage data comes from single-cell transcriptomics and it is used
to recover the evolutionary path of cells in a given environment. The finer res-
olution of single-cell assays such as single cell RNA sequencing experiments
(scRNAseq) in comparison with aggregated ”bulk” data provides cell-specific
data. Applications include for example studies in immune systems (Stubbing-
ton et al., 2017; Miragaia et al., 2017), virus-host interactions (Cristinelli and
Ciuffi, 2018), hematopoiesis (Wilson and Göttgens, 2018; Dharampuriya et al.,
2017) among others. In particular, single-cell assays allow to trace back the
“history” of fully differentiated cells starting from their precursors, so they
have become very important to the study of cell lineages (Stubbington et al.,
2017).
A typical cell lineage dataset contains a sample of cells from a certain
tissue along with cell-specific transcriptional profiles obtained, for example,
from scRNAseq. Such profiles exhibit differences that are associated with the
development stage of the cell. For instance, stem cells evolve into fully differ-
entiated cells according to a process characterized by gradual transcriptional
changes. Therefore, important differences are observed in transcription pro-
files along the development path of the cell. Another potential application
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concerns temporal transformation of the cells, e.g. during cancer progression.
Lineage inference is then carried out to identify the underlying path of devel-
opment from the initial state of the cell until its matured states. For a more
detailed description of the objectives and challenges of lineage inference, see
Korthauer et al. (2016) .
Figure 3.1: Left panel: Three-dimensional representation of single-cell gene
expression profiles based on principal component analysis (data of Fletcher
et al. (2017)); cells are colored by cluster. Right panel: results using the
“Slingshot” method of Street et al. (2018).
Typically, the process of estimating the latent tree in cell lineage prob-
lems is done in three sequential steps. First, dimension reduction methods are
applied to summarize information from the high dimensional scRNAseq data;
then clustering of the cells is carried out in the reduced dimensional space;
finally, the latent tree is inferred given the estimates of the partition of cells.
Figure 3.1 illustrates the results of this sequential approach applied to a lin-
eage cell lineage dataset. Notice how in Figure Figure 3.1 (and the following
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discussion) the data includes observations on all nodes of the tree, not only the
leaves. This is because the data is a snapshot of cells accross all intermediate
steps in the evolution of the cells.
Shiffman et al. (2018) introduce a generative model based on a Dirichlet
diffusion process (Neal, 2003). This model, however, despite introducing a
notion of tree along which cell evolution occurs, the model does not favor
simple trees with well dinstinguished clusters of cell. Trees from a Dirichlet
diffusion process are generated on a latent space via Brownian motion and
thus do not enforce neither a partition nor a parsimonious representation of
the data.
In contrast, Street et al. (2018) develop a method (“Slingshot”) that
takes as input a partition of the cell lines into different cell types and returns
a smooth version of the underlying MST defined by the clusters’ centroids:
the paths from root to leaves are smoothed by principal curves. The Slingshot
procedure requires observations to be clustered, which is done sequentially
by a k-means algorithm for instance, before the construction of a minimum
spanning tree on the cluster centroids. Such sequential approach (of first fixing
the partition of cells, then using the centroids as nodes of the MST) is very
common in the bioinformatics literature despite its assumption that the lineage
structure (represented by the MST) does not play a role in clustering the cells.
Such assumption is not biologically ideal.
In the following section we propose an inference approach that uses a
model-based Bayesian perspective such as in Shiffman et al. (2018), but in
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the context of mixtures as in “Slingshot”. That is, we propose a Bayesian
dependent mixture model for cell lineage inference. The mixture components
represent clusters of cells in the same development stage and the dependence
is defined by a latent random tree with nodes that correspond to the centroid
of the clusters. The cluster and lineage structures are modeled jointly and as
a consequence, the lineage represented by the random tree structure is allowed
to affect the clustering of cells. Full posterior inference on the clusters, the
random tree and pseudotimes are obtained by Markov chain Monte Carlo
(MCMC).
3.1.2 Dependent mixture models
The proposed model is a variation of Bayesian mixture models in which
dependent priors are assumed. Clusters of cells should be dependent on each
other due to the fact that mixture components represent distinct interme-
diate states in the continuous process of cell development. Most literature
on Bayesian mixture models assumes a priori independent cluster-specific pa-
rameters, with some exceptions. Xu et al. (2016) describe the application of
determinantal point processes (DPP) (Kulesza and Taskar, 2012) in Bayesian
mixture models as a way to impose repulsive stochastic behaviour for the prior
on the mixture components. The motivation comes from the observation that
similar mixture components do not make the model more flexible. Conversely,
they only create redundancy and hurt the interpretability of the components.
In the context of cell lineage data, the repulsive nature of the DPP would
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enforce the intermediate states of cell development to be dissimilar from each
other.
Another motivation for dependent mixtures is the sharing of informa-
tion between the different groups, causing a shrinkage effect that is also a
form of regularization. Mixed effect models is a key example of the use of
hyperpriors for regularization (Lindstrom and Bates, 1990; Alston et al., 2012;
Lachos et al., 2013). In Bayesian non-parametrics, hierarchical Dirichlet pro-
cesses (Teh et al., 2006) incorporate shrinkage effect by assuming dependent
component-specific Dirichlet processes (DP) Gj ∼ DP (α0, G0) for mixture
components j = 1, . . . , K with a common base measure G0 that is itself a
DP. Since DPs generate discrete random measures with the countably infinite
support consisting of an iid sample from the base measure, it follows from the
discreteness of G0 that all Gj, j = 1, · · · , K will all share the same atoms.
An application of mixture models with predictor-dependent compo-
nents is described in Chung and Dunson (2011). The authors define a Dirich-
let process that assigns stick-breaking weights and atoms to random locations
in predictor space, therefore obtaining random probability measures (which
define the distribution of the mixture components) indexed by covariates in a
continuous way.
Our proposal is to define dependence on the components of the mixture
in a way that explicitly incorporates the biological structure that characterizes
cell lineage applications. We therefore propose the use of a random tree struc-
ture not only to explain the snapshot in the latent space of the continuous
54
development of cells from its initial stage into mature differentiated cells, but
also to model the dependence structure between the clusters of cells. Regular-
ization is incorporated in the form of a penalization on trees with too many
nodes or with redundant edges. Our proposed model builds upon the slingshot
model in Street et al. (2018) in which a Minimum Spanning Tree is calculated
given the estimated centroids of the clusters of cells in a latent low dimen-
sional space. The authors then use projections onto the MST to get a point
estimate of the pseudotimes for each cell. In contrast, by formally construct-
ing a Bayesian mixture model with random trees on such latent space, we
are able to provide full inference (with uncertainty captured by the posterior
samples obtained through MCMC) on the clusters of cells, on the underlying
tree structure and also on pseudotimes. In addition, the model assumes the
partition of cells to depend on the lineage structure.
3.2 Dependent Mixture Models for Cell Lineage Data
Let yi ∈ RD denote the recorded markers for the ith cell. In a study
of cell lineage, the raw data could be biomarkers, i.e., protein levels for some
selected proteins. The raw data are typically further processed by extracting,
for example, the first few principal components which become the data yi in
the upcoming discussion.
We start the construction of a Bayesian inference model by assuming







wj N(yi | µj,Σj). (3.1)
The parameter vector includes, in particular, the number of terms in the
mixture, k + 1, the location parameters µj and the covariance parameters for
each cluster in the mixture model, and the relative weights wj, j = 0, . . . , k.
In words, we assume a mixture of normals for the data yi, including
cluster-specific covariance matrices Σj and cluster-specific location parameters
µj. Next, we introduce a dependent prior across µj. Dependence is supported
by the nature of the cell subpopulations being biologically related as part of
the cell differentiation process.
Recall that the goal is to infer a structure that reflects the cell evolu-
tion path and its possible branching, starting with an original cell population
indexed by k = 0 (and biologically known to be the root population). We
represent this cell evolution path as a tree that includes the terms µj in the
mixture model (3.1) as the vertices, which are connected by edges that rep-
resent the cell differentiation. An additional set b = (b1, . . . , bk) of indicator
variables bj ∈ {0, . . . , k} records the tree structure by specifying for each node
the index of the parent node. The root node, j = 0 has no parent. A prior on
the tree implicitly defines the prior probability model for the mixture compo-
nent locations µj, as described in Sections 3.2.1 and 3.2.2.
In order to define a meaningful notion of cell evolution, we need to
carefully choose the form of such tree. This is achieved by defining a tree with
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a globally-dependent structure, which is able to induce repulsions between
the branches and to avoid redundant components. For example, we avoid
the possibility of a tree to grow back into itself. In fact, cell evolution fol-
lows a “monotonicity” requirement in the sense that cell characteristics evolve
towards progressive degrees of differentiation, not going back to an undiffer-
entiated stage.
We introduce a preference for such structure using the notion of a min-
imum spanning tree (MST), whose origin traces back to Boruvka (1926). A
MST is an edge-weighted, undirected graph that connects all vertices together,
without any cycles and with the minimum possible total edge weight. The
weight on an edge is the distance between the two nodes of the correspond-
ing edge. In such a way, the most likely tree induces the desired parsimony
requirement. In fact, given a set of nodes representing the different cell sub-
populations, a MST can be seen as the most parsimonious way to represent
the cell lineage.
We consider two alternative priors for (k,µ1, . . . ,µk) based on a MST.
One model is centered around trees that constitute a MST of the locations µj,
but also allows trees that are not MST. The second model restricts the tree to
be a MST, making b a deterministic function of (µ0, . . . ,µk).
3.2.1 Soft MST-dependent prior
Let Tk = (k,µ1, . . . ,µk, b1, . . . , bk) denote the tree, including cluster
locations µj (note that µ0 is known and hence no prior is assigned to it) and
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tree structure b. The soft-MST (s-MST) prior defines a dependent prior on
the cluster locations as














with b restricted to tree structures, i.e., no cycles and a single known root in
µ0. Also, notice that (3.2) includes k as a random variable.
In equation (3.2), d(µi,µj) denotes the Euclidean distance between
two nodes µi and µj. The terms q(k) and q(µj) are reference probability
models. We use q(µj) ∼ N(µj | m0, σ20I) where I denotes the identity matrix
of dimension D. The penalty parameter α controls the level of shrinkage
towards a MST, with α = 0 implying no shrinkage and α → ∞ implying a
deterministic restriction to MSTs. In summary, equation (3.2) is the prior on
the random tree. It is difficult to visualize p(Tk) by way of prior simulation.
It is important to notice that q(k) and q(µj) are not the marginal
models for k and µj. The marginal distributions are implicitly determined by
q(k), q(µj) and by the parameter α. In fact, conditionally on k, the model in
(3.2) reduces to









































dµ1 . . . dµk
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is an intractable normalizing constant. The marginal prior on k can be written
as p(k) ∝ Zk q(k) with normalization constant
∑∞
k=1 Zk q(k). It is easy to see
that p(µ1, . . . ,µk, b, k) defined in (3.2) is proper (see Appendix C.1).
The dependence among the centers is induced by the exponential term,
that penalizes complex branching structures; for example, in trees with too
many nodes or with redundant edges. Therefore, the prior can be seen as a
regularization term, that is ballanced by the likelihood, which tends to favor
complex trees that provide better fit to the training data. The parameter α
determines the strength of the regularization implied by the prior in compar-
ison with the likelihood of the data. Implicit in (3.2) is the fact that the only
branching structures b allowed are the ones that span trees with no internal
cycles.
This joint prior, despite presenting an intractable normalizing constant,
induces simple conditionals. For example, note that





∀i = 0, . . . , k, ∀j = 1, . . . , k (3.3)
and that










Equations (3.3) and (3.4) reflect the repulsive effect of the prior on the branch-
ing structure. In fact, the conditional distribution for b favours minimum
spanning trees by assigning smaller probabilities to redundant structures, e.g.
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branches that grow back. This can be seen by the fact that each branch is
selected to be the shortest (with larger probabilities) among those who pre-
serve the spanning structure of the tree. In the case α→ +∞, this procedure
has several analogies with Prim’s algorithm (see Prim, 1957). In the opposite
case, i.e. when α → 0, the prior on the trees is invariant with respect to the
branching structure and the centers are independent. The model in this case
corresponds to a finite mixture model with a prior on the number of compo-
nents. In general, the model does a soft assignment of the branches to a MST
structure (s-MST).
The conditional prior on the means, instead has a different effect. Each
center is drawn from a linear combination of the independent prior term and
the position of its parent and children. The larger the α parameter, the more
evident the attraction towards the barycentre of parent and children. More-
over, note that if the distance d chosen is the squared euclidean, the conditional
distribution of each µj is still normal, with updated parameters, i.e.


















+ 2α(1 + fj)
}−1
I. (3.6)
where fj is the number of children of node j and (m0, σ
2
0) are the prior hyper-
parameters of q(µj). The Gaussian prior on (µj|µ(−j), b, k) is a fundamental
feature that will imply posterior conditional conjugacy.
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For the weights and the kernel covariance we use conditionally conju-
gate priors,
Σ0, . . . ,Σk ∼ IW (ν,Ψ)
(w0, . . . , wk) | k ∼ Dir(δ, . . . , δ) (3.7)
α ∼ Exp(λ0)
k ∼ Geom(k − 2|r0), k ≥ 2.
3.2.2 Hard MST-dependent mixture model
The prior in (3.2) formalizes a preference for parsimonious structure by
favoring mixture models with clusters that are connected by a tree with short
cumulative length. By favoring shorter cumulative length the model shrinks
the tree structure towards a MST, but stops short of insisting on the tree
actually being a MST. The model defines a joint prior p(µ, b) on the cluster
locations µ = (µj)
k
j=1 and the tree b. An alternative model, named here as
hard-MST (h-MST), defines a prior on µ only and implies b by introducing
the MST as a deterministic function b = MST(µ) of µ:








exp [−αW {MST (µ1, . . . ,µk)}] .
(3.8)
The term MST(µ1, . . . ,µk) in equation (3.8) represents the minimum
spanning tree with nodes µ1, . . . ,µk and edges Eµ1,...,µk ⊂ {1, . . . , k}
2. The
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function W denotes the total length of a graph, which is defined by the sum
of the squared lengths of its edges. Therefore, we have




By taking the lengths of the edges squared to define the length of
the whole tree, we preserve conjugacy for the component specific means. By
enforcing the MST structure the h-MST model provides stronger parsimony
(in terms of favoring simpler tree structures) if compared with the s-MST. The
parameter α regulates the strength of influence of the MST on the clustering
structure: the higher its value, the simpler the underlying tree structure due
to a stronger penalization on the length of the MST.
Under the h-MST, the priors for the remaining parameters are the same
as described in section 3.2.1 equation (3.7) for the s-MST.
As mentioned in subsection 3.1.1, there is a crucial difference between
our modeling approach and the two-step slingshot algorithm of Street et al.
(2018) with regards to the dependence relationship of the cell lineage and the
cluster centroids. Although the hard MST-dependent mixture model defines
the MST as a deterministic function of the cluster centers, it implies a reg-
ularization effect of the tree structure on the distribution of the centroids by
favoring cluster-specific means that lead to simpler (shorter) MSTs. On the
other hand, the clustering step in Street et al. (2018) does not make use of the
underlying lineage structure represented by the MST.
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All full conditional distributions for this model are analytically avail-
able, except for p(µj | y, rest) for which a Mtropolis-Hastings step was imple-
mented. More details are available in Appendix C.3.
3.3 Posterior Inference
In this section, we present the posterior simulation scheme to infer the
tree structure, the optimal clustering configuration, as well as the estimation
of the pseudotimes for each cell. For both the s-MST and h-MST models, the
inference procedure is done via reversible jumps MCMC.
For inference with an unknown number of components k we added a
prior k ∼ Geom(k − 2|r0), k ≥ 2 and implement transdimensional posterior
simulation, to accommodate the variable dimension of the parameter vector
as k changes. The soft-MST prior uses reversible jump MCMC (RJ-MCMC)
(Green, 1995) to implement trans-dimensional transitions. Proposing a tree
also requires a proposal for the branching structure. However, given k nodes
the total number of spanning trees is kk−2, implying a curse of dimensionality
for even fairly moderate values of k. This would in turn lead to inefficient
proposals, which cause the algorithm to mix poorly.
In order to overcome this issue, we propose a variant of the RJ-MCMC
which has been previously used in Xu et al. (2016) and Lee et al. (2015). De-
note the parameters with θk = (µ1, . . . ,µk, b1, . . . , bk, w0, . . . , wk,Σ0, . . . ,Σk).
In the RJ-MCMC, a proposal that involves a change of k to k̃ would re-
quire to propose also a new set of parameters θ̃k̃. In practice, the joint pro-
63
posal for a “new” dimension and a “new” set of parameters, decomposes in
q(θ̃k̃, k̃|θk, k) = q(θ̃k̃|k̃, k, θk) q(k̃|k). In practice, it is difficult to make good
proposals q(θ̃k̃, k̃ | θk, k) and q(θk, k | θ̃k̃, k̃) with reasonable acceptance prob-
abilities.
We follow an approach from Lee et al. (2015) nd Xu et al. (2016).
The idea is to split the data into two parts: a small training set y′ that
serves the purpose of creating informative proposal distributions, and a test
set y′′ to evaluate the acceptance ratio. Let p1(θk|y′) = p(θk|k, y′) denote the
posterior distribution under k using the training sample y′. We use p1 in two
instances. First, we replace the original prior term p(θk|k) and, second, we
also use it as proposal distribution q(θ̃k̃|k̃). The test data y′′ is then used to
evaluate the acceptance probability. By the nature of the Metropolis-Hastings
acceptance probability the proposal distribution and the prior factor in the
target distribution cancel out, making this a feasible strategy, i.e.













p(k̃) p(y′′|θ̃k̃, k̃) q(k|k̃)
p(k) p(y′′|θk, k) q(k̃|k)
}
, (3.9)
The strategy has an analogy with model comparison via fractional Bayes fac-
tors (O’Hagan, 1995).
Performing inference for a fixed size tree is straightforward under the
soft-MST. In particular, the full conditionals are available in closed form and
easy Gibbs sampling updates can be implemented (details are described in
Appendix C.2).
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Inference under the h-MST with fixed tree size is similar to s-MST. Full
conditionals are also analytically available, except for the component-specific
means µ1, . . . ,µk, which are sampled according to a Metropolis-Hastings step.
In summary, each full conditional p(µj | µ(−j),y, rest), j = 1, . . . , k is
a finite mixture of truncated normals with non-overlapping truncation regions
which are hard to determine analytically. The issue of sampling from p(µj |
µ(−j),y, rest) is avoided when approximating it by the efficient Metropolis-
Hastings proposal










where Sj = {I : ci = j} and Vj denotes the ser of neighbors of node j in
the current MST (µ). The proposal is built so that the acceptance probability
equals 1 if the set of neighbors of j in MST (µ̃j, µ
(−j)) equals Vj. For further
details, see Appendix C.3.
3.3.1 Optimal partition
Once the posterior distribution is obtained vvia MCMC, it is necessary
to assign each observation to a cell subpopulation, which corresponds to a
point estimate of the partition of cells a posteriori. Although the posterior
includes also values for the visited partitions {c(m)}Mm=1 where m denotes the
MCMC iterations, finding a point estimate for a random partition is non-trivial
due to the cardinality of the space of partitions (Bell number). The posterior
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mode, for example, is not an adequate solution as each support point might
have a negligible posterior probability. In the Bayesian literature, a common
approach is to use a decision theoretic framework. In practice, one introduces
a suitable loss function L(cn, ĉn) giving the cost of estimating the “true” cn
by ĉn. Then, a Bayes optimal estimate is given by any partition ĉn which
minimizes the posterior expectation of the loss function. In other terms, the
loss is averaged across all possible true clusterings, where the loss associated
to each potential true clustering is weighted by its posterior probability. For
example, the posterior mode corresponds to the 0 − 1 loss, i.e. L0−1(c, ĉ) =
1(c 6= ĉ). This loss function is not satisfactory because a partition which
differs from the truth in the allocation of only one observation is penalized
the same as a partition which differs from the truth in the allocation of many
observations. To alleviate this issue, Dahl (2006); Lau and Green (2007); Wade
et al. (2018) propose different loss functions. In this work, we use the Variation
of Information loss, whose theorerical results were developed in Wade et al.
(2018).
3.3.2 Estimation of pseudotimes
Starting from a pre-specified root node (which in our case represents
the cluster center of stem cell), pseudotime for a data point in the mixture
is defined as the cumulative length of the shortest path starting at the root
and ending at the closest projection of the data point onto the latent tree.
Pseudotimes are a deterministic function of the latent tree structure. Since
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MCMC simulation produces a posterior sample of realizations of the latent
random tree (as a function of locations µj and branching structure b), the
same simulation output implies a posterior sample on pseudotimes.
In the context of inference for cell lineage, inference on pseudotimes
relates to the time a cell takes to develop from the initial state until it reaches
its current stage of development.
3.4 Simulated Datasets
Here we show results of posterior inference under s-MST and h-MST for
two simulated datasets, and compare them with inference under the slingshot
method. The first dataset was generated as a Gaussian mixture model with
independent components that are chosen to replicate the structure of a random
tree. The second dataset comes from a simulation dataset by Street et al.
(2018) designed to infer how accurate is the recovered branching structure.
3.4.1 Simulation 1
We first assess the model with a stylized example consisting of a dataset
simulated via a mixture model on an underling tree (see Figure 3.2, left panel).
Soft MST
In Figure 3.2 (right) we show the posterior sampled trees, which seem
to reconstruct well the underlying truth. In Figure 3.3 we show that the s-MST
model produced a parsimonious estimate of lineage structure with 6 clusters
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Figure 3.2: Fit of the s-MST model. The left panel shows the simulation truth.












Figure 3.3: Posterior density estimate obtained via the s-MST model. The
observations are colored according to the optimal cluster labeling.
Hard MST
Inference under the h-MST model is done via transdimensional MCMC
according to Section 3.3 (full conditional distributions are described in Ap-
pendix C.3). First, we run very short parallel MCMC chains (5 iterations)
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with fixed number of components k ranging from 2 to 15. In this first step,
the full conditionals in Appendix C.3 are computed using only the training
data and transdimensional moves are not proposed. The second step consists
of 10000 iterations of the transdimensional MCMC in which changes in the
number of components k are proposed as in Section 3.3 followed by the regular
Gibbs sampling updates listed in Appendix C.3. Finally, cluster membership
point estimates ĉ := (ĉ1, . . . , ĉn) are obtained based on those 10000 iterations
following Wade et al. (2018). Fixing c = ĉ (which also implies a fixed posterior
estimate on k) we run the update steps 2-5 in C.3 for more 5000 iterations.
Table 3.1 shows the results of the estimation of k under different ini-
tial number of mixture components k0 ∈ {2, 8, 15} and different fractions of
training data ε ∈ {0.1, 0.25, 0.5, 0.75} reserved for proposing transdimentional
moves. In general, the h-MST favors more parsimonious trees in comparison
with the s-MST prior. Here, the results from both soft and hard models are
quite similar. The h-MST model recovers 6 clusters for most configurations of
k0 and ε. Notice how in the simulation, one of the centroids could be ”erased”
without causing big differences in the underlying tree. The h-MST therefore
provided a more parsimonious tree in comparison with the s-MST.
Figure 3.4 shows the posterior estimates on the MST structure and
cluster membership for k0 = 8 and ε = 0.5. The branching structure is well
recovered by the h-MST model with six clusters instead of the simulated truth
of 7, which was also observed with the s-MST. We can see that using one node
less than the in the simulation true, did not compromise the overall branching
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structure of the tree.
Table 3.1: Estimated number of clusters k under the hMST model. The
methodology of Wade et al. (2018) was applied to the first 10000 iterations
of the transdimensional MCMC under different choices of ε (fraction of data
reserved as training) and k0 (value of k used in the initialization of the MCMC
algorithm).
k0 = 2 k0 = 8 k0 = 15
ε = 0.1 3 6 6
ε = 0.25 4 6 6
ε = 0.5 6 6 6
ε = 0.75 6 6 6































Figure 3.4: Estimated branching structure of the hMST model with k0 = 8
and ε = 0.5 based on the last 5000 MCMC iterations. When the cluster
membership indicators are fixed at the point estimate a posteriori, clusters 7
and 8 are empty.
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Slingshot
When analyzing the results of applying k-means (k=7) for recovering
the clustering of cells followed by the slingshot algorithm to the simulated
data, we noticed that some initializations lead to cluster structures that do
not correspond to the truth under simulation. This issue is fixed once we
consider a higher number of random initializations and select the one with
best value of the objective function (Figure 3.5). The slingshot algorithm is
robust to the choice of k, specially when picking large values of k in the k-means
algorithm. The method however does not account for statistical uncertanty,

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.5: Parallel runs of slingshot applied to the simulated data for k
ranging from 4 to 11. Clusters are estimated by the best result among 10
random initializations of the k-means algorithm.
71
3.4.2 Simulation 2
We now apply the algorithm to the same simulated dataset presented
in Street et al. (2018). In Figure 3.6 (left) we show samples from the posterior























Figure 3.6: Left panel: Plot of the posterior sampled trees. Right panel:
posterior density estimate obtained via the s-MST model. The observations
are colored according to the optimal cluster labeling.
Hard MST
Again, we run 15000 iterations of MCMC on h-MST model. The first
10000 iterations include transdimensional proposal based on splitting the data
into training and test, while the last 5000 are evaluated conditionally on the
VI point estimate for the cluster membership structure. The h-MST model
enforces more parsimony than the s-MST, which can be seen in Figure 3.7 as
fewer components (five) are identified by MCMC.
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ε = 0.1 ,    α = 0

























ε = 0.1 ,    α = 10
Figure 3.7: Results of posterior estimation of MST. Curves in gray are the
posterior sampled MST and the black tree in the point estimate a posteriori.
α represents the strength of regularization towards simple MST structures that
is implied by the hMST prior on µ. ε is the fraction of the data reserved as
training for the purpose of building the transdimensional proposals.
3.5 Mouse Data
We analyze data from a single cell RNA-seq experiment on horizontal
basal cells (HBC) from the adult mouse olfactory epithelium (Street et al.,
2018). The goal is to infer the continuous progression from stem cells into
terminal mature cells and to estimate the cell-specific pseudotimes.
Due to the heterogeneity of cell populations, the analysis of traditional
transcription data, such as bulk microarrays, does not allow researchers to
discover cell dynamics. In fact, the underlying signal can be potentially masked
when averaging over thousands of samples (Korthauer et al., 2016), possibly
compromising statistical power.
The original data (before preprocessing) is available on GEO in GSE95601
and also in https://github.com/drisso/fletcher2017data. Preprocessing follows
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the steps in (Perraudeau et al., 2017), which are listed here for completeness.
The dataset originally contains measurements for 28284 genes throughout 849
cells. A total of 102 low-quality cells are removed from the dataset and the
1000 most variable genes are retained.
The resulting data is then normalized and the dimension is further
reduced to 50 by fitting a Zero-Inflated Negative Binomial-based Wanted
Variation Extraction (ZINB-WaVE) model following Risso et al. (2018). The
ZINB-WaVE assumes a zero inflated negative bionomial model to extract low-
dimensional signal from the data, accounting for dropouts (inflation of zeros),
over-dispersion, and the count nature of the single cell RNA-seq data. Finally,
multidimension scale (MDS) (Mardia et al., 1979) is applied to reduce the
dimension further to 2 (this is the only deviation from Perraudeau et al. 2017
in which the dimension is reduced to 5). MDS consists of a rearrangement of
the observations in a lower dimensional space (dimension 2 here) based on the
matrix of pairwise distances computed using all the original 50 dimensions.
Hard-MST model. We start by showing results of application of the model
that enforces MST structure (Section 3.2.2). The RJMCMC was run for 3000
iterations. The first 2000 are used to obtain a point estimate for the cluster
membership indicators ci according with Dahl (2006) and also for the number
of mixture components k. The final 1000 iterations are run with fixed ci and
k. The hyperparameters were chosen as r0 = 0.5, a0 = b0 = 10, σ
2
0 = 1, λ0 = 1
and δ = 1 to reflect non-informative prior knowledge.
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Figure 3.8 shows the estimation of the underlying minimum spanning
tree. We estimate 8 nodes with one branching leaving the main path of the
spanning tree (green). The right pannel illustrates the posterior uncertainty
on the edges of the tree and highlights the proximity of green cluster with both
the purple and the yellow clusters.



























ε = 0.1 ,    α = 0



























ε = 0.1 ,    α = 2.5
Figure 3.8: Posterior estimates of the latent MST and clustering membership
structure based on the last 5000 MCMC iterations. Left panel: independent
mixture (α = 0). Right panel: MST dependent mixture (α = 2.5).
We now focus on posterior estimation of pseudotimes. For each MCMC
sample (after burn-in) we construct a posterior sample for the cell-specific
pseudotimes as a deterministic transformation of the underlying MST. Such
transformation is defined by calculating the distance along the tree from its
root node to the projection of the cell onto the closest edge in the tree. Let
Ti(τ) denote the pseudotime for cell i. Figure 3.9a illustrates the evaluation
of Ti(τ), where the particular tree in the plot is fixed as the MST τ deter-
mined by the posterior point estimates for the cluster centers. The right panel
shows marginal posterior standard deviations for the cell-specific pseudotimes,
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conditional on cluster membership. Such graphical summaries help to identify
those cells that are more prone to missclassification for being at approximately
equal distance from two or more branches in the MST.





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.9: Left panel: Estimated pseudotimes for each cell. The extremes
0 and 1 were chosen arbitrarily. Right panel: posterior standard deviation
of pseudotimes for each cell. Axis represent the two components of the MDS
transformation.
In Figure 3.10, we can have a broader view of the estimated pseudotimes



















Figure 3.10: Cluster specific boxplots of median posterior pseudotimes ob-
tained for each cell.
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Slingshot. The slingshot method is a multistep algorithm that produces an
underlying MST conditional on a fixed estimate of the cluster centroids. The
algorithm first computes the MST with the clusters’ centroids as nodes. Then
it fits for each leaf a principal curve that smooths the path from the root to
that leaf along the corresponding branches of the MST. Each principal curve
represents a cell different development path.
We now investigate the sensitivity of the slingshot method to the clus-
tering of cells. We apply multiple independent runs of k-means algorithm
initialized at random with k=8. Figure 3.11 shows that the resulting MST is
highly dependent on the initialization of the k-means algorithm, in some cases
omitting important branches or creating artificial branches that clearly do
not correspond to distinct cell populations. However, picking the best among

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.11: Multiple runs of slingshot applied to the mouse data. Each plot
corresponds to a distinct random initialization of k-means algorithm (k=8).
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.12: Multiple runs of slingshot applied to the mouse data. Each plot
corresponds to the best result among 10 distinct random initializations of k-




We developed a dependent mixture model for single cell RNA sequenc-
ing data to estimate cell lineages. The proposed model takes into account the
underlying tree in the transformed data on a lower dimension when defining
the cluster structure of the cells: the model penalizes cluster allocations that
define over complex trees. We presented two forms of defining such penaliza-
tion terms: under soft MST or hard MST.
Motivated by the cell lineage applicaion, we deffined a dependent prior
based on tree alignment. Other applications might give rise to dependence
based on alignment of clusters on other, more general graphs.
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Chapter 4
A Two Step Bayesian Model for Matching
Cell Line and Patient Genomic Profiles
4.1 Introduction
In a precision medicine paradigm, the patient’s specific genetic archi-
tecture is assessed to propose a personalized treatment that is expected to
be optimal for that individual. In this context, there is a trend in modern
medicine to move from generalized treatment approaches towards the tailored
treatment strategy that is dictated by their genomics or molecular profile. This
paradigm shift accelerates the needs for advances in pharmacogenomics tech-
nology and associated analytical methods. In this paper, we develop methods
to meet this demand, inclduing in particular novel priors for random struc-
tures. Briefly, we propose developing an integrative statistical framework, that
merge multiplatform genomics (’omics, in short) profiles from multiple model
systems (e.g. patients and cell-lines) for finding significant drug targets, pre-
clinical models for appropriate drug discovery and repurposing and, finally, to
calibrate therapeutic potential for future patients. By identifying these sim-
ilarities (and differences) across model systems, we are able to gather more
refined information about the patient than what is contained in their specific
profile, while still proposing a personalized treatment that is strongly tied to
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the patient’s profile - through appropriate integration of various data sources.
The objective of this paper is then to construct a novel Bayesian statis-
tical approach for matching patient gene profiles with cell line profiles. Such
inference is needed, among many other applications, for data integration, pre-
cision medicine and patient specific treatment assignment. The expansion of
modern medicine and fast growth of research in health sciences have led to a
great increase in available data on multiple sources/platforms such as The Can-
cer Genome Atlas (TCGA, tcga-data.nci.nih.gov), Cancer Cell Line Ency-
clopedia (CCLE, portals.broadinstitute.org/ccle), International Cancer
Genome Consortium (ICGC, icgc.org) to name a few. A model-based ap-
proach for matching of a patient profile with data from other sources, such
as from cell lines, allows us to access a wider range of information to predict
a patients response to specific treatments. Important for the envisioned ap-
plication, the matching should be carried out on the basis of a biologically
meaningful signal only, putting aside mere noise.
A cell line is a culture of cells extracted from a tissue (e.g., cancer cells
from a tumor in a human tissue) and grown in an in-vitro environment that
simulates the environment of the tissue in the organism where it was extracted.
Therefore, cell lines serve as models to study cancer biology. Information from
the response to a drug or treatment applied to cell lines (cultivated in-vitro)
is used to infer about the expected response in vivo (Goodspeed et al., 2016).
Similarly, individuals can be grouped according to similarities between their
profiles and observed profiles in a fixed set of cell lines. In such scenarios, the
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mapping of cell lines and patients opens the possibility to construct treatment
recommendations based on results for the corresponding cell lines (Sinha et al.,
2015). We propose a statistical approach that seamlessly combines the output
of the Bayesian mixture model based on a proposal by Parmigiani et al. (2002)
with a novel two-way Bayesian non-parametric (BNP) mixture model that is
constructed as an extension of a BNP bi-clustering model of Lee et al. (2013).
Parmigiani et al. (2002) propose a Gaussian-uniform mixture model for
probability of expression (POE). Later in the model construction we shall use
the latent trinary signal of the POE model to carry out nested clustering of
patient samples and the desired matching with cell lines. The uniform compo-
nent in the POE models havier tails associated with genes that are over- and
under-expressed, while the Gaussian term corresponds to regularly expressed
genes. The authors argue that, by trichotomizing gene expressions into these 3
categorical levels, the POE approach smoothly removes uninformative biolog-
ical and instrumental noise that is naturally present in genomic profile data,
therefore strengthening downstream analysis.
The clustering of patient samples and the desired match with cell lines
builds on a model developed of Lee et al. (2013), who present a Bayesian model
(NoB-LoC) that identifies genes (columns) that are relevant for clustering of
samples/individuals (rows). The identified genes are then partitioned in such
a way that genes within the same subgroup (column-wise clusters) give rise to
a common nested partition of individuals (row-wise clusters). The approach
is motivated by the observation that high-dimensional protein profiles make it
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hard to find meaningful clusters of samples/individuals. Researchers therefore
often restrict attention to groups of proteins that are expected to lead to
more meaningful and interpretable results. NoB-LoC identies such groups in
a seamless process, together with the nested clustering of samples. The NoB-
LoC model conveniently allows for different clustering of samples with respect
to different groups of proteins. In our context, this translates to association
of cell lines and patients depending on the set of proteins in the profile.
Developing the outlined model consturction, this chapter makes two
major contributions: the first one is the integration of POE with the two-way
clustering building on the NoB-LoC model. The second, and perhaps more
important contribution is the extension of the NoB-LoC model to allow for ex-
plicit probabilistic matching of profiles that could come from distinct sources
(e.g., cell lines and patients). In short, in the proposed approach we first use
the NoB-LoC model to partition the proteins according to a zero enriched
Pólyia urn process where some proteins are set aside as inactive proteins,
while the selected proteins are grouped into protein clusters (active proteins).
Within each protein cluster, the samples are partitioned again, using a par-
tition model that matches patients to cell lines. The motivation is that the
usually high-dimension protein profiles make it hard to find similar samples to
be clustered together, therefore restricting the attention to groups of proteins
is expected to lead to more meaningful and interpretable results. This pro-
cedure also naturally allows for identification of co-expressed proteins in the
form of protein clusters, i.e. a group of genes that are biologically correlated
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are also expected to have their expression levels ”tied together” along different
samples. Finally, the NoB-LoC model conveniently allows for different cluster-
ing of samples depending on the subsample of proteins that is considered. In
our problem, this translates to association of cell lines and patients depending
on the set of proteins in the profile.
The real data used in the statistical analysis comes from an experi-
ment using reverse phase protein arrays (RPPA) which record the expression
of selected proteins simultaneously on multiple cell lines and patients samples
(Charboneau et al., 2002). The dataset analyzed here consists of lung can-
cer protein expressions (233 proteins) measured in 687 patients and 124 cell
lines. Data is batch corrected, i.e., they are also adjusted for the batch effect
difference between cell line and patients’ data).
4.2 POE Model
In this section we describe the POE (probability of expression) model
defined in Parmigiani et al. (2002). We modified some of the priors in or-
der to obtain analytical full-conditionals for as many parameters as possible,
which facilitates the MCMC implementation in the larger, encompassing model
(more details ahead and also in appendix D.1).
Each observation ysg consists of expression levels for protein (gene)
g ∈ {1, . . . , G} and sample s ∈ {1, . . . , S}. Latent variables esg indicate high
expression of gene g in sample t (esg = 1), normal expression (esg = 0) and
under expression (esg = −1). Each possible value of esg determines a differ-
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ent distribution for the observed gene expressions according to the following
Gaussian-Uniform mixture model
(ysg | esg) ∼

Unif(αs + µg, αs + µg + k
+
g ), if esg = 1,
N(αs + µg, σ
2
g), if esg = 0,
Unif(αs + µg − k−g , αs + µg), if esg = −1.
The lengths k+g and k
−
g of the support of the uniform components should
cover the tails of the corresponding gene expression distribution implying heav-
ier tails than the Gaussian distribution. Under normality, the great majority
of the samples (probability 0.997) concentrate within 3 standard deviations
from the mean; therefore the constraints k+g > k0σg, k
−
g > k0σg imply heavier
than Gaussian tails for fixed values of k0 greater than, say, 3.
We now define the weights for each term in the mixture by the proba-






g ), g ∈ {1, . . . , G} where π+g = P (esg = 1 | πg),
π0g = P (esg = 0 | πg) and π−g = P (esg = −1 | πg). We assume (πg | ηπ) ∼
Dirichlet(ηπ).
Figure 4.1 illustrates the implied mixture model in the context of den-
sity estimation. The augmentation of the parameter space with inclusion of
indicatior variables est allows for identification of up- and down-regulated genes
that are not well captured bythe light tails of a single Gaussian component.
Posterior probabilities of differential expression are determined by Bayes
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Figure 4.1: Left panel: Weighted components of the Gaussian-Uniform mix-
ture model. Right panel: density estimates using Gaussian-Uniform mixture
(black line) and using kernel estimate (gray line). Vertical bars represent data
generated from the Gaussian-Uniform mixture.
rule as
p+sg := P (esg = 1 | ysg,πg, f1,g, f0,g)
=
π+g f1,g(ysg)





× 1(ysg ∈ Sf1,g)
=
π+g f1,g(ysg)
π+g f1,g(ysg) + π
0
gf0,g(ysg)
× 1(ysg ∈ Sf1,g), (4.1)
where 1(·) is the indicator function and Sf1,g denotes the support of f1,g.
Analogously,
p−sg : = P (esg = −1 | ysg,πg, f−1,g, f0,g)
=
π−g f−1,g(ysg)
π−g f−1,g(ysg) + π
0
gf0,g(ysg)
× 1(ysg ∈ Sf−1,g). (4.2)
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Equations (4.1) and (4.2) are used for visualization of sample specific
gene profiles. Since p+sg and p
−
sg are not simultaneously positive, the differences
dsg := p
+
sg−p−sg will fall in the interval [−1, 1], therefore serving as a unidimen-
sional measure of gene expression ( dsg ≈ 1 for highly expressed and dsg ≈ −1
for underexpressed genes).
The model is completed by the prior specification (µg | θµ, τµ) ∼
N(θµ, τµ), (αs | µα, τα) ∼ N(µα, τα) restricted to
∑S
s=1 αs = 0, (σ
2
g | γ, λ) ∼
InvGamma(γ, λ), (k+g | αk+ , βk+) ∼ InvGamma(αk+ , βk+), (k−g | αk− , βk−) ∼
InvGamma(αk− , βk−).We also chose prior models for hyperparameters as θµ ∼
N(mµ, s
2
µ), τµ ∼ InvGamma(aτµ , bτµ), αk+ ∼ Exp(λαk+ ), αk− ∼ Exp(λαk− ),
βk+ ∼ Gamma(aβk+ , bβk+ ), βk− ∼ Gamma(aβk− , bβk− ).
The motivation to propose Inverse Gamma priors for k+g , k
−
g and Dirich-
let prior for πg is to make use of conjugacy results in the full-conditional pos-
terior of these parameters, which was not originally explored in Parmigiani
et al. (2002).
4.2.1 Posterior inference for the POE model
We implement posterior inference by MCMC simulation. All full con-
ditionals are available in closed form due to the choice of contditionally con-
jugate priors/hyperpriors; the only exceptions are αk+ and αk− . We therefore
implement Gibbs sampling transition probabilities for all parameters except
(αk+ | y, else) and (αk− | y, else). For the latter we use Metropolis-Hastings
transition probabilities with random walk proposal on logαk+ and logαk+ re-
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spectively. See appendix D.1 for more details.
To avoid numerical instability when sampling from truncated inverse
gamma distributions (full conditional posterior distributions for k+g and k
−
g ),
we used a variable augmentation scheme proposed in Damien and Walker
(2001). The prior on the auxiliary variables introduced by the authors imply
full-conditional posterior distributions for those variables, which are sampled
together with the original parameters of the POE model within the full MCMC
algorithm.
4.3 Nonparametric Bayesian Clustering with Patient
and Cell Line Matching
4.3.1 A nested random partition and matching structure
Following posterior simulation for the POE model, the posterior esti-
mated values dsg become the inputs for model-based clustering of proteins and
samples and the desired pairing with cell lines. This is implemented by the
construction of a nested partition model that builds on the Nonparametric
Bayesian local clustering (NoB-LoC) model defined in Lee et al. (2013). In
this section, we relabel the data dsg as d
c
ig if sample s corresponds to the i-th
cell line or as dpig if it is the i-th patient. The subindex g still denotes protein
g. We will assume the dataset contains G proteins and S samples, including
Np patient samples and N c cell line samples (Np +N c = S).
The model first partitions the proteins according to a zero enriched
Pólya urn. One special cluster (corresponding to the zero-enrichment) is in-
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terpreted as ”inactive proteins”. The remaining ones are grouped into protein
clusters (active proteins). Within each of these protein clusters, the samples
are partitioned again by a second, nested partition model. The nested par-
tition model includes also the desired pairing of each patient sample cluster
with a matching cell line.
Consider the cluster membership indicator wg for each protein g =
1, . . . G and denote w = (w1, . . . , wG) the vector of protein cluster indicators.
Let π0 be the probability of inactivation and let α0 > 0 be the potential for
creating a new cluster. Finally, define nk := #{g; wg = k} the number of
proteins that fall into protein cluster k, for k = 0, 1, . . . , Kw with k = 0
denoting the cluster of inactive proteins and Kw denoting the total number
of active clusters of proteins determined by w. Then the zero enriched Pólyia
urn defines p(w | π0) as






g=1(α0 + g − 1)
, (4.3)
and for short we write (w | α0, π0) ∼ ZEPU(α0, π0).
For each cluster of proteins defined by w, two dependent partitions of
the samples are defined, the first one involving patients only, and the second
one (which is stochastically dependent on the partition of patients) includes
only cell lines. The cluster membership indicators for the i-th patient and i-th
cell line in k-th cluster of proteins are defined as δp,ki and δ
c,k
i , respectively.
The two partitions are then determined by the cluster membership indicators
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for patients and for cell lines. We marginally model the cluster membership
of patients δp,k := (δp,ki )
Np
i=1 as δ
p,k ∼ ZEPU(αpk, πpk). This implies a random
number Jk of active clusters of patients within the k-th group of proteins.
Conditionally on δp,k, several choices of priors on δc,k are possible, each
of them representing one way of matching cell lines’ to patients’ profiles.
Discrete uniform prior: we assume a discrete uniform prior for δc,k on the
patient samples and the set of inactive samples: δc,ki | δ
p,k ∼ Uniform({0, 1, . . . , Jk}).
Discrete uniform prior with at most ` cell lines per cluster of samples:
the conditional prior on (δc,k | δp,k) has the p.m.f












i = j) ≤ ` ∀j ∈ {1, . . . Jk}
}
.
In the special case ` = 1 for example, the multiplicative normalization constant











Conditional zero inflated Polya urn: a conditional zero inflated Polya
urn prior distribution is assumed prior for δc,k | δp,k as a continuation of the
process of clustering patient samples. This means that the initial probability
of allocation of cell lines to a patient cluster is proportional to the cluster size.
Stochastically, this approach is equivalent to a joint zero inflated Polya urn
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for all samples.
We consider the Gaussian sampling model (dcig | θcig, σ2g) ∼ N(θcig, σ2g)








g) for cell line i and patient j and protein g. The
prior for θxig with x being either c or p is
θxig ∼

Iθ∗jg , if δ
x,wg





i = 0 and wg > 0 (active prot. inactive smpl.)
N(µ2g, σ
2
2g), if wg = 0 (inactive prot.),
(4.5)
where Ix denotes the point mass distribution (Dirac measure) at x. In (4.5)
(first equation) we define the unique mean responses θ∗jg for active proteins
and samples. We denote by Jk the number of active sample clusters for all
proteins g such that wg = k. Notice that active cell lines and patients share
the same mean response if they belong to the same sample cluster.
For the purpose of deriving the MCMC algorithm for posterior infer-
ence, we marginalize the patient specific (and cell line specific) means θxig in



















g), if wg = 0 (inactive prot.).
(4.6)
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The prior for the unique mean response values is specified as θ∗jg ∼
N(µ0g, σ
2
0g) with hyperpriors σ
−2
g ∼ Gamma(ag, bg), τ−2lg ∼ Gamma(alg, blg)
and µ0g, µ1g, µ2g
iid∼ N(m0, s20).
4.3.2 Summarizing the posterior nested partition
Point estimates of the cluster-membership indicators are obtained using
the approach proposed by Dahl (2006). We run the MCMC algorithm and,
after judging (practical) convergence, we evaluate for each pair i < j of tumors





K is the Monte Carlo sample size and pijk is an indicator for i and j being
allocated to the same cluster, i.e., pijk = 1⇔ egi = egj during iteration k. The
dependence on g is omitted from the notation for clarity. The pijk and the
p̂ij are combined into (I × I) matrices P (k) = [pijk] and P̂ = [p̂ij]. We then
report as posterior estimated δ̄ the partition corresponding to the co-clustering
matrix P (k
∗) that minimizes ||P̂ − P (k)||. In other words,
P (k
∗) = arg min
k
||P̂ − P (k)||.
That is, k∗ indexes the Monte Carlo sample whose co-clustering matrix is




4.4.1 Simulation 1: POE
We carry out a first simulation to validate inference under the POE
model.
We simulate a dataset with 100 samples and 20 genes assuming the POE
model as the underlying truth. Some small changes were done in the simu-
lation process that deviates slightly from the model in section 4.2. Namely,
σ2g was sampled from σ
2
g = N(0, 0.25)
2 + 1 instead of an Inverse Gamma
prior and k+g , k
−
g were both sampled from max(Gamma(8, 1), 5σg) instead of
max(InvGamma(8, 1), 5σg). Hyperparameters were fixed as ηg = (1, 1, 1),
µα = 0, τα = 0.5, θµ = τµ = 1.
To carry out the MCMC inference procedure, we fix ηg = (1, 1, 1), µα =
0, τα = 100, aτµ = bτµ = aβk+ = bβk+ = aβk− = bβk− = λαk+ = λαk− = 0.01,
γ = λ = 0.1, mµ = 0 and s
2
µ = 100. Such values were chosen to represent
weak prior information.
Figure 4.2 shows that the estimated cluster membership assignment of
the observations reasonably recovers the simulation truth (compare pannels
(a) and (b) ). Panel (c) shows how the POE model removes noise from the
data and highlights the biologically meaningful levels of protein activation
(low, medium, high).
Figure 4.3 shows the density estimates a posteriori for 4 genes, compar-
ing the true protein-wise cluster assignment with the point estimates obtained
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with the methodology from Dahl (2006) as described also in 4.3.2. The cluster
membership indicators are typically well recovered. Notice that when 2 com-
ponents are enough to estimate the underlying density among the different
samples, we might have the absence of one of the groups of proteins with low,
medium or high expression (see g = 15 for example). Also, the use of uniform
components can, in some cases, exhibit high density near the center of the re-
sulting mixed distribution therefore producing samples of medium expression
even when the true is esg = ±1 in the simulation.
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(a) Simulated ysg ordered by true esg.
(b) Simulated ysg ordered by estimated esg.
(c) dsg ordered by true esg.
Figure 4.2: (a): Simulated data ysg. Samples in each column are sorted by true
esg. (b) Simulated data ysg. Samples in each column are sorted by estimated
E (esg | y). (c) Differences dsg = p+sg − p−sg with the same ordering as in panel
(a). The ordering of samples change according to the protein (column) but is
the same throughout the 3 panels.
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||| |||| || ||| ||| || ||| |||| | |||
−20 −10 0 10 20
ysg − α̂s − µ̂g ,    s = 1, ..., S
||| |||| || ||| ||| || ||| |||| | |||
g =  2
|||| | |||| ||| | |||| ||| || | || |||
−20 −10 0 10 20
ysg − α̂s − µ̂g ,    s = 1, ..., S
|||| | |||| ||| | |||| ||| || | || |||
g =  6
| | | ||| | | || || ||| | || || ||| | | ||| | ||| ||| | ||
−20 −10 0 10 20
ysg − α̂s − µ̂g ,    s = 1, ..., S
| | | ||| | | || || ||| | || || ||| | | ||| | ||| ||| | ||
g =  15
| |||| || | | || | || |||| || ||| || | || | |||| ||
−20 −10 0 10 20
ysg − α̂s − µ̂g ,    s = 1, ..., S
| |||| || | | || | || |||| || ||| || | || | |||| ||
g =  18
Figure 4.3: Posterior density estimates. Vertical bars represent centralized
gene expressions ysg−µg−αs, s = 1, ..., S for all genes g collored according to
its estimated cluster membersip indicators (top) and true cluster membership
indicators (bottom). Full lines represent the best fitting uniform and normal
components of the mixture a posteriori multiplied by the respective weights.
Dashed line corresponds to a kernel density estimate based on the vertical
bars. Color code: black = -1, red = 0, green = 1.
4.4.2 Simulation 2: nested partitions
In this section we describe the simulation to validate inference on the
NobLoc model. We replicated the scenario in Lee et al. (2013), with 100
samples and 20 proteins. The simulation truth incorporates the local clus-
tering feature of first partitioning proteins and then within protein cluster,
partitioning the samples. However, instead of simulating the protein and sam-
ple partitions according to a zero inflated Plya urn, we fixed the partition of
proteins upfront to have two active protein clusters, the first one containing
proteins with 3 active sample clusters; and the second containing 4 proteins
with 2 active sample clusters. The cluster-membership assignment of sam-
ples was made uniformly at random among the available sample clusters. The
cluster specific means were fixed at the same values in Table 1 of Lee et al.
(2013). Inactive samples and proteins were all sampled from Unif(−0.8, 0.8).
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The standard deviation of the Gaussian sampling model for active samples
was fixed at σg = 0.1 For an illustration, see Figure 4.4 panel (a).
In Figure 4.4 panel (b) we can see that the underlying cluster structure
was reasonably captured by the NobLoc model. The only discrepancy is the
inclusion of protein 19 in the first active cluster together with proteins 1 -
8, instead of classifying it as an inactive protein according to the simulation
truth.
(a) Simulated ysg ordered by
true cluster assignments.
(b) Simulated ysg ordered by
estimated cluster assignments.
Figure 4.4: (a): Observations ordered according to the simulation truth. (b):
Observations ordered according to estimated cluster membership indicators a
posteriori. In both panels, rows represent samples while columns represent
proteins.
4.5 Lung Cancer Dataset
4.5.1 The data
The dataset consists of protein profiles coming from an RPPA exper-
iment on lung cancer samples. The data records 233 proteins that were pre-
selected for their biological relevance to the study of this type of cancer. The
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data records samples from 687 patients and 124 cell lines. The objective is to
identify groups of similar patients and cell lines with respect to subgroups of
co-expressed proteins (we informaly say that proteins are co-expressed if their
expressions are correlated). We therefore expect that the samples (patients
and cell lines) can be partitioned in a different way depending on the group of
co-expressed proteins that is considered.
4.5.2 Results
We describe here the results of a joint inference of the POE model and
nested clustering by NoB-LoC. We start by analyzing the results of directly
applying the NoB-LC model to the original lung data (without running POE
first), which is illustrated in Figure 4.5 (a).
Figure 4.5: Observed protein expression arranged according to posterior esti-
mated cluster structure under NoB-Loc. Only active proteins are displayed.
Panel (a) shows the result of application of the NobLoc model on the original
data and panel (b) shows the results after the application of POE.
Figure 4.6 shows one of the blocks in Figure 4.5 in more details high-
lighting the similarities between the cell lines and proteins in that block. Sam-
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ples are reasonably homogeneous in terms of the expressions of the particular
subgroup of proteins shown in the figure. Notice also that some proteins
present typically high expression while others typically present low expression
considering the particular group of samples.
Figure 4.6: Protein expressions within one of the samples/proteins blocks of
Figure 4.5 (b). The cell lines and patients exhibit very similar profiles when
considering the subset of proteins that were clustered together by the model.
4.6 Discussion and Future Directions
Some innovations were introduced in this chapter: (i) The model nat-
urally accounts for co-expression of genes and/or proteins in a manner that
allows distinct clustering of samples depending on each estimated subgroup
of co-expressed functional units or pathways; (ii) We develop efficient models
for matching patients and cell line profiles. Development of such inferential
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tools is of critical relevance to implementing precision medicine, since it can
be used for potential treatment assignment that is specific to a patient, and
borrows information not only from that patient, but also from cell lines coming
from external sources. The latter is critical also because experiments with cell
lines can be carried out freely. (iii) Third, the approach does not need to be
restricted to cell lines and patients but can be generalized to multiplatform
omics profiles from diverse model systems such as patient-derived xenographs
(PDX) models and organoids.
This chapter makes two important methodological contributions in
Bayesian non-parametrics: (i) the seamless integration of the (modified) prob-
ability of expression (POE) model for noise reduction and the nested bi-
clustering approach; (ii) the formal probabilistic modeling of co-clustering be-
tween cell lines and patients based on profile similarities via dependent priors
on partition models.
There are some areas that need to be more thoroughly investigated.
One of them is the need to extend the simulation studies where the underly-
ing truth differs from the POE and NobLoc models in order to address the
performance of the proposed methodology under model misspecification. In
our results, we restricted the matching of cell lines and patients to a condi-
tional zero inflated Pólya urn (see section 4.3.1), therefore the investigation of
the other models for matching information from cell lines to patients is also
proposed as a future work.
One of the limitations of the oroposed approach is the computational
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effort of full posterior simulation. Alternative implementations based on vari-
ational inference for example are possible alternatives (see section 1.4).
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Chapter 5
Conclusions and future directions
The common theme of the three major projects in this thesis was the use
of dependent priors for mixtures and random partitions. We discussed some
motivating examples where the scientific research questions naturally give rise
to such dependent structures. Information on a specific form of dependence
represents potentially useful expert knowledge, which should be exploited when
available. It is still common practice, however, to ignore such domain knowl-
edge and proceed with default independent priors. For the specific examples
discussed in this thesis we constructed suitable dependent models, developed
practicable posterior inference methods and demonstrated the proposed ap-
proaches in simulation studies and in the actual applications.
Many open questions remain. For the application to cell lineage data,
the approach proposed in Chapter 3 can be characterized as an empirical
fit to the data with a model that respects the dependencies that arise from
the nature of the data. In future research we plan to consider alternative
generative models that mimick the actual biologic process of how cells diversify.
A generative model is used, for example, in Shiffman et al. (2018), however
still without using restrictions and informative priors that would arise from
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the nature of the data.
Also for the problem of matching patients and patient clusters with
representative cell lines that we considered in Chapter 4, many open questions
remain. In the currently proposed model we match each patient cluster with
one representative cell line, implicitly allowing each cell line to be paired with
only one patient cluster. This restriction could be removed, giving rise to a
slightly different random structure. Another aspect of the problem is that
investigators have a preference for reporting very distinct clusters of proteins
(genes) and similarly for the nested clusters of patients. That is, the desired
summary of the random partition should perhaps take into account preferences
for parsimony and interpretability. And such preferences could alternatively
already be included in the prior probability model. One approach is the use of
repulsive prior probability models that favor very distinct clusters, for example
the determinantal point process (DPP) (Xu et al., 2016). Similar issues arise






Here we describe the parameterization used for some of the probability
distributions referred throughout the text. Namely: Gamma, Inverse Gamma,
Exponential, Laplace, univariate and multivariate Student T (with location-
scale parameters), univariate and multivariate Gaussian.
A.1 Normal
A continuous random variable X follows a normal distribution N(µ, σ2)












, x ∈ R.
It follows that E(X) = µ and V ar(X) = σ2.
A.2 Multivariate Normal
A continuous random vector X ∈ Rd follows a d−variate normal dis-
tribution N(µ,Σ) if its density is
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(X − µ)>Σ−1(X − µ)
}
, x ∈ Rd,
for Σ positive definite. It follows that E(X) = µ and V ar(X) = Σ2.
A.3 Gamma
A continuous random variableX follows a Gamma distribution Gama(a, b)




xa−1e−bx, x > 0.
It folows that E(X) = a
b




A continuous random variableX follows an Inverse Gamma distribution
with parameters a and b, i. e., X ∼ GamaInv(a, b) if the random variable






x , x > 0.
It follows that E(X) = b





A continuous random variable X follows a Stident T distribution with



















, x ∈ R.
In this case, we denote X ∼ T (ν, µ, σ). Under this parameterization,
we have E(X) = µ if ν > 1 and V ar(X) = σ2 × ν
ν−2 for ν > 2. For ν = 1, the
average of the Student-T is not defined and if ν ≤ 2, the same holds for the
variance.
A.6 Multivariate Student-t
A continuous random vector X ∈ Rd follows a multivariate Student-T




d+ (x− µ)′Σ−1(x− µ)
]−n+d
2 x ∈ Rd.
In this case, we denoteX ∼ Tn(µ,Σ). Here µ is the location parameter
and the positive definite matrix Σ is the scale matrix. In this parameterization,
E(X) = µ if ν > 1 and V ar(X) = Σ × ν
ν−2 for ν > 2. Similar to the
unidimensional case, forν = 1 the mean of the distribution is not defined and
if ν ≤ 2, the same happens for Σ.
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An important result states that if X ∼ Tn(µ,Σ), then the marginals
are Student are also Student-T: Xi ∼ Tn(µi, σ2i ) where µi is the i-th entry of
the mean vector and σ2i = Σi,i.
A.7 Laplace
A continuous random variable X ∈ R+ follows a Laplace distribution









, x > 0.
In this case, we denote X ∼ Laplace(λ, µ, σ). It follows that X ∼
Laplace(λ, µ, σ)⇒ E(X) = µ and V ar(X) = 2σ2.
A.8 Negative Binomial
A disctrete random variable X follows a Negative Binomial distribution




(1− p)npx, x = 0, 1, 2, . . .
In this case, we denote X ∼ NegBin(n, p).
Under such parameterization, E(X) = np





A continuous random variableX follows a LogNormal(µ, σ) distribution
if the random variable Y := logX follows a normal distribution N(µ, σ2). In













, x > 0.
It follows that E(X) = eµ+
σ2
2 and V ar(X) = (eσ
2 − 1)e2µ+σ2 .
109
Appendix B
Appendix for Chapter 2
B.1 Full Conditionals
We briefly describe the full conditional posterior distributions, num-
bered (1) through (9) below, that define the transition probabilities in the
Gibbs sampler MCMC implementation. We define Ψ := (θ,y) as the random
vector that includes the full parameter vector as well as the data, and we use
the notation Ψ−a to represent Ψ excluding component a.
1. Updating v0u, u = 1, 2, 3:




















2. Updating µ0u, u = 1, 2, 3:













v00 + CDL× κuv0u
,
1
v00 + CDL× κuv0u
)
.





















where u1 = (1, . . . , 1, 0, . . . , 0)
>, u2 = (0, . . . , 0, 1, . . . , 1, 0, . . . , 0)
> and
u3 = (0, . . . , 0,
1, . . . , 1)> with 1’s in positions 1, . . . , τ 1cd` (for u1), in positions τ
1
cd` +
1 . . . τ 2cd` (for u2) and in position τ
2
cd` + 1 . . . T (for u3), respectively.




















Σ−1c u1 + µ01v01
 ,
where Pmcd1 := {1 ≤ i ≤ I : δ1cdi = m}.
Similarly, (µ∗cd`2(m) | Ψ−µ∗cd`2(m)) ∼ N(a2, b2), with


























Σ−1c u2 + µ02v02
 ,
where Pmcd2 := {1 ≤ i ≤ I : δ2cdi = m}.
And (µ∗cd`3(m) | Ψ−µ∗cd`3(m)) ∼ N(a3, b3), with






















Σ−1c u3 + µ03v03
 .
4. Updating Σc: Under the normal-inverse Wishart conjugate model we
get











(ycdi`j − µcd`i)(ycdi`j − µcd`i)> + VΣc
)
5. Updating γ:





















6. Updating τ 1cd` and τ
2




cd` in different blocks
of the Gibbs sampler. This way we evaluate fewer scenarios than in the
case of sampling both together in a single step, due to the restriction
τ 1cd` < τ
2
cd`.





















If evaluating the probabilities in (B.1) is too computationaly intensive,
one can alternatively implement a Metropolis-Hastings transition proba-
bility, proposing unit increments or decrements, subject to the constraint
τ 1cd` < τ
2
cd`. This would require at most four evaluations of the right hand
side product in (B.1).
7. Updating cluster membership indicators δ1cdi: If δ
2
cdi ≤ κ1, then
δ1cdi is equal to the value of δ
2
cdi with probability 1. Otherwise, by
multinomial-Dirichlet conjugacy results, the full conditional distribu-
tion of δ1cdi is P (δ
1









j N(ycd`ij | µcd`i,Σc) with µcd`i evaluated under δ1cdi =
m.
8. Updating cluster membership indicators δ2cdi: The full conditional
p.m.f. for δ2cdi is given by
P (δ2cdi = m | Ψ−δ2cdi) ∝
{
γ ×N2cdi(δ1cdi) if m = δ1cdi.
(1− γ)× π2m−κ1N
2





j N(ycd`ij | µcd`i,Σc) with µcd`i being calculated
assuming δ2cdi = m.
9. Updating π1 and π2: under the conjugate multinomial-Dirichlet
















cdi = m) for m = κ1 + 1, . . . , κ1 + κ2. Then (π1 | Ψ−π1) ∼
Dir(η11+n
1
1, . . . , η1κ1+n
1
κ1





B.2 Number of Model Parameters for AIC and BIC
Here we describe how the number of parameters was determined when
evaluating the BIC criterion in sections 4 and 5 and AIC in section 4. The
description focuses on BIC, but the same arguments are valid for evaluation
of AIC.
The number of parameters for a given model is a function of κ1 and κ2
that can be decomposed as N(κ1, κ2) = f(κ1, κ2)+const, where const depends
on the number of data points, but not on κ1 or κ2. The only parameters
in the likelihood that vary in number as κ1 and κ2 change are {µ∗`,u : c ∈
[C], d ∈ [D], ` ∈ [L], u ∈ [3]}, which contains f(κ1, κ2) = CDL(2κ1 + κ2)
parameters. Therefore, BIC = 2 log p(y | θ) − N(κ1, κ2) log n, where n is
the number of observations, hence the comparison of any pair of models is
invariant with respect to the term const and we can, for simplicity, consider
N(κ1, κ2) = CDL(2κ1 + κ2).
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Appendix C
Appendix for Chapter 3
C.1 Proper Prior on (µ1, . . . ,µk, b1, . . . , bk, k)



















k dµ1 . . . dµk = k
k <∞.
Without loss of generality, we can truncate P (k) to have suport 1 ≤ k ≤ M
for some finite upper limit M and therefore p(k) will be also proper. The
truncation is justified in practical appications since one expects finite number
of nodes in the tree.
C.2 Full Conditional Distributions for the s-MST Model
We now describe posterior inference under the s-MST model of Section
3.2.1. A simple MCMC can be implemented in such a scenario, leading to the
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Gibbs sampling transition probabilities:
1. Updating ci:
p(ci = k|yi,µk,Σ, wk) ∝ L(yi|ci = k,µk,Σ) p(ci = k|wk)
∝ wk N(yi;µk,Σ), ∀k = 0, . . . , k.
2. Updating w:
p(w|c1, . . . , cn) ∝ p(c1, . . . , cn|w) p(w)
∼ Dirichlet(n0 + δ, . . . , nk + δ).
3. Updating Σ:





















ν + n,Ψ +
∑
i




4. Updating µk,∀k = 1, . . . , k:

















where fj,µp,Σp were defined in equations (3.5) and (3.6).
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5. Updating the branching structure: by resampling it from the prior con-
ditionals p(bj = i|µ0, . . . ,µk, b(−j), k) described in (3.3).
6. Updating the dimension K using a RJ-MCMC move:
(a) Generate a proposal k̃ ∼ q(k̃|k) and a matching set of parameters
θ̃k̃ ∼ p1(θ̃k̃|y′) as described in Section 3.3
(b) Accept (k̃, θ̃k̃) with probability α defined in (3.9).
C.3 Full Conditional Distributions for the h-MST Model
First, we list the full conditional distributions for implementation of
Gibbs sampler on the model described in Section 3.2.2 conditionaly on the
dimension k.
1. Updating cj:
p(ci = j|yi,µj,Σj, wj, k) ∝ L(yi|ci = j,µj,Σ) p(ci = j|wj)
∝ wj N(yi;µj,Σj), ∀j = 0, . . . , k.
2. Updating w:
p(w|c1, . . . , cn, k) ∝ p(c1, . . . , cn|w, k) p(w | k)
∼ Dirichlet(n0 + δ, . . . , nk + δ).
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3. Updating Σ−1
p(Σ−1 | y, rest) ∝
n∏
i=1
p(yi | µci ,Σ
−1)p(Σ−1)
∼ Wishart
n+ ν,[Ψ−1 + n∑
i




The conditional posterior density p(µj | y, rest) is not straightforward
to either write in analytic form or to sample from.
Denote by Sj := {i : ci = j} the set of observations that belong to
cluster j. Combining the likelihood with the h-MST prior, we have







× exp {−αW(MST (µ1, · · · ,µk))} ,
in which the sum W(MST (µ1, · · · ,µk)) involves different terms depend-
ing on the position of µj in R
D. This leads to the full conditional being a
finite mixture of truncated normals, with non-overlapping truncation re-
gions Al ⊂ RD, l = 1, . . . , n such that the neighbors of any node µj ∈ Al
are the same under the MST (µ1, . . . ,µk) when we fix the remaining
nodes µ(−j). The challenge lies in defining the regions Al that partition
RD.
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However, we can build a tractable and efficient Metropolis Hastings
proposal q(µ̃j | µj;µ(−j),y, rest) to approximate p(µj | y, rest). We
will omit the dependence on variables other than µj from the nota-
tion for clarity of exposition, therefore writing q(µ̃j | µj) instead of
q(µ̃j | µj;µ(−j),y, rest). We define q(µ̃j | µj) as follows. Take from the
edges Eµ1,...,µk of the MST (µ1, . . . ,µk) the subset Vj = {i : {j, i} ∈
Eµ1,...,µk} of all neighbors of node j. We propose a new component
specific mean µ̃j from










which simplifies to q(µ̃j | µj) ∼ N(µ̃j; aj,Bj), where Bj = (|Sj|Σ−1+











By denoting the proposed neighborhood of µ̃j as Ṽj = {i : {i, j} ∈
Eµ∗1,...,µ∗k} where µ
∗
l = µl if l 6= j and µ∗j = µ̃j, the resulting Metropolis
Hastings acceptance probability equals 1 if Ṽj = Vj and
α(µ̃j | µj) = min
{
1,
q(µj | µ̃j)p(µ̃j | y)






























































Appendix for Chapter 4
D.1 Full Conditionals for the POE Model
Here we briefly describe how to sample from each one of the full con-
ditionals. In this section, we use 1(·) to denote either an indicator function
or th support of a truncated probability distribution. We also define the sets







t are defined analogously.
Updating esg




× 1(αs + µg < ysg < αs + µg + k+g ), if x = 1,
π0g ×N(ysg; αs + µg, σ2g), if x = 0,
π−g
k−g
× 1(αs + µg − k−g < ysg < αs + µg), if x = −1.











{ysg − αs − µg}, k0σg
))
.











(πg | y, else) ∼ Dirichlet
(






















































M+g = max{ysg − αs; t ∈ P+g } − k+g ;
M−g = max{ysg − αs; t ∈ P−g };
m+g = min{ysg − αs; t ∈ P+g };









ag = bg ×
σ−2g ∑
t∈P0g
(ysg − αs) + τ−1µ θµ
 .
Updating αs























M+t = max{ysg − µg − k+g ; g ∈ P+t };
M−t = max{ysg − µg; g ∈ P−t };
m+t = min{ysg − µg; g ∈ P+t };
















































(µg − θµ)2 + bτµ
)
Updating βk+
(βk+ | y, else) ∼ Gamma
(







(βk− | y, else) ∼ Gamma
(







p(αk+ | y, else) is not analytically available since









One way of (approximately) sampling from this distribution is through
the Metropolis-Hastings scheme.
We specify a proposal q(αnewk+ | αoldk+ ) corrected by the acceptance prob-
ability α(αnewk+ | αoldk+ ) := min
{
1, r(αnewk+ | αoldk+ )
}
, where
r(αnewk+ | αoldk+ ) :=
q(αoldk+ | αnewk+ )p(αnewk+ | y, else)
q(αnewk+ | αoldk+ )p(αoldk+ | y, else)
.
Our proposal is a random-walk on logαk+ , i.e., logα
new
k+ ∼ N(logαoldk+ , V +)
for some fixed V + > 0. which implies a LogNormal proposal density on the
original scale with q(αnewk+ | αoldk+ ) = N(αnewk+ ;αoldk+ , V +)× 1/αnewk+ .
It is straightforward to verify that
log r(αnewk+ | αoldk+ ) = (logαoldk+ − logαnewk+ )−G
[
log Γ(αnewk+ )− log Γ(αoldk+ )
]
+
+ (αnewk+ − αoldk+ )
[
G log βk+ −
G∑
g=1




Updating αk− is entirely analogous to updating αk+ .
D.1.1 Sampling from truncated distributions within MCMC
In this section we describe the Gibbs sampler augmentation scheme to
asymptotically sample from the truncated inverse gamma and truncated nor-
mal distributions that appear in appendix D.1. Although sampling algorithms
for truncated distributions can be easy derived, sometimes even by the inverse
c.d.f. method, the resulting algorithm can often be numerically unstable (take
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the truncated Gaussian distribution for example). In such cases, it could be
advantageous to use an approximate sampler if it is more robust to computa-
tional errors. In this regard, we follow the directions on Damien and Walker
(2001).
The univariate normal sampling scheme can be seen as a particular
instance of the algorithm for multivariate normals or as an extension of the
sampling scheme for univariate standard normals that are both described in
Damien and Walker (2001). The algorithm to sample from truncated inverse
gamma is very similar to the one that samples from the truncated Gamma. We
describe both sampling schemes here solely for the purpose of completeness.
D.1.1.1 Truncated normal
Suppose a truncated Gaussian distribution for the random variable X:






1(a < x < b), where
we could have a = −∞ or b = +∞ to represent unilateral truncation. We
define the auxiliary variable Y through the joint density
fX,Y (x, y) ∝ 1(0 < y < e−
(x−µ)2
2σ2 )1(a < x < b)
so that the implied marginal for X matches the original N(µ, σ2)1(a < X < b).
The full conditional distributions are
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Within the MCMC scheme described in section D.1, we include sam-
pling from the auxiliary variables Yµg and Yαt corresponding to the full con-
ditional distributions of µg, and αt respectively. The auxiliary variables are
sampled from (D.1) while the original variables are sampled from (D.2), with
the appropriate values of µ, σ2, a and b.
D.1.1.2 Truncated inverse gamma
Suppose X ∼ InvGamma(α, β)1(a < x < b), i.e., fX(x) ∝ x−α−1e−
x
β
1(a < x < b). We define the joint density of X and Y :
fX,Y (x, y) ∝ x−α−11(0 < y < e−
x
β )1(a < x < b)
so that the implied marginal forX matches the original InvGamma(α, β)1(a <
X < b). The full conditional distributions are
(Y | X = x) ∼ Unif(0, e−
x
β ), (D.3)
fX|Y (x | y) ∝ x−α−11(M(y) < x < b), (D.4)





. The inverse c.d.f. method provides an ef-








which will be distributed as (D.4).
Within the MCMC scheme described in section D.1, we include sam-
pling from the auxiliary variables Yk+g , Yk−g and Yσ2g corresponding to the full




g respectively. The auxiliary variables
are sampled from (D.4) while the original variables are sampled from (D.3),
with the appropriate values of α and β.
D.2 Full Conditionals for Matching Cell Line and Pa-
tients Model
This appendix describes steps of the Gibbs sampler algorithm used to
carry out posterior inference.
Define Sx,kj := {i : δ
x,k
i = j} with x being either c or p. In the remainder
of this appendix section, we will denote by sj the single element in the set S
c,k
j
(it could even be sj = ∅), omitting the superscripts for simplicity.
The full posterior (up to a normalizing constant depending solely on
the data d) can be factorized as
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p(dcig | θ∗jg, σ2g)1(Sc,kj ={i}6=∅) ∏
i:δp,ki =j









p(dcig | µ1g, σ2g , σ21g)
∏
i:δp,ki =0








p(dpig | µ2g, σ2g , σ22g)
Nc∏
i=1















































We follow Bush and MacEachern (1996) and sample the cluster mem-
bership indicators δp,k within a Gibbs block marginalizing θ∗ out, i.e., by
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sampling p(δp,ki = j | d,Ψ−(δp,ki ,θ
∗
)
) for i = 1, . . . , Np. These updates together
with the previous one where we sampled θ∗jg ∼ p(θ∗jg | Ψ−θ∗jg) for all j and g,
asymptotically provides a blocked joint sample from p(θ∗, δp,k | d,Ψ
−(δp,k,θ∗)).
Denote by A−p,k the number of active patient samples within protein
sample k excluding patient i and define Sp,k−j := S
p,k
j \ {i}. Then δ
p,k ∼
ZEPU(αp,k, πpk) implies










, j = 1, . . . , J−k




Using equation (D.6), we obtain
P (δp,ki = j | δ
c,k, δp,k−i ) ∝ p(δ
c,k | δp,k)P (δp,ki = j | δ
p,k
−i )













analytically. Notice that Jk varies with δ
p,k
i so the summation term cannot by
omitted from (D.7).






















(|Sp,k−j |σ−2g + σ−20g )(|S
p,k−





























Using equation (D.7), we get















































where J−k is the number of active clusters of patients within protein group k
after removing patient i and bj := 1(|Sc,kj | = 1)1(|S
p,k
j | > 0)+1(|S
c,k
j | = 0) is a
binary variable that enforces non-empty active clusters of cell lines to contain
at least one patient sample as well.
Updating δc,ki :









1g), j > 0, S
p,k








1g), j = 0
0, otherwise.
We also define a Metropolis-Hastings algorithm to sample from δc,k in
a way that hopefully produces Markov Chains with better mixing properties.
Here we omit the upper indexes c, k from δc,k for clarity of exposition.
Recall that the Metropolis-Hastings algorithm produces a new sample
δt+1 from δt according to an auxiliary transition probability q(δt+1 | δt) that
is irreducible and aperiodic. Then δt+1 is accepted with probability α(δt+1 |





We define two types of transitions and at each iteration we uniformly
chose one of them at random.
Type I: We take an active cell line and switch it with one of the





this proposal, the acceptance ratio reduces to
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where i1(x) and i0(x) respectively denote the active and inactive cell lines
selected by the proposal at time x (before switching, when x = t; and after
switching, when x = t+ 1).
Type II: Randomly pick an active cluster j. If |Sc,kj (t)| = 0 (no active
cell line in cluster j), assign an inactive cell line to cluster j uniformly at
random. On the other hand, if |Sc,kj (t)| = 1 we reassign the only active cell
line i ∈ Sc,kj (t) from cluster j to the group of inactive cell lines by making
δc,ki (t+ 1) = 0. Under such proposal, we have q(δ





1(|Sc,kj | = 1). Under this proposal,































, Sc,kj (t) = {i} 6= ∅.
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